|
US5821088A
(en)
*
|
1990-05-11 |
1998-10-13 |
Siga Pharmaceuticals, Inc. |
Use of gram-positive bacteria to express recombinant proteins
|
|
GB9015198D0
(en)
*
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US6172197B1
(en)
|
1991-07-10 |
2001-01-09 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
US6916605B1
(en)
|
1990-07-10 |
2005-07-12 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
DE4122599C2
(de)
*
|
1991-07-08 |
1993-11-11 |
Deutsches Krebsforsch |
Phagemid zum Screenen von Antikörpern
|
|
DK1024191T3
(da)
*
|
1991-12-02 |
2008-12-08 |
Medical Res Council |
Fremstilling af autoantistoffer fremvist på fag-overflader ud fra antistofsegmentbiblioteker
|
|
US6743929B1
(en)
*
|
1992-08-25 |
2004-06-01 |
G. D. Searle & Co. |
Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
|
|
IT1270939B
(it)
*
|
1993-05-11 |
1997-05-26 |
Angeletti P Ist Richerche Bio |
Procedimento per la preparazione di immunogeni e reagenti diagnostici,e immunogeni e reagenti diagnostici cosi' ottenibili.
|
|
SE9304060D0
(sv)
*
|
1993-12-06 |
1993-12-06 |
Bioinvent Int Ab |
Sätt att selektera specifika bakteriofager
|
|
US6576236B1
(en)
|
1994-07-01 |
2003-06-10 |
Dana Farber Cancer Institute |
Methods for stimulating T cell responses by manipulating a common cytokine receptor γ chain
|
|
EP0739981A1
(en)
*
|
1995-04-25 |
1996-10-30 |
Vrije Universiteit Brussel |
Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
|
|
US6090382A
(en)
|
1996-02-09 |
2000-07-18 |
Basf Aktiengesellschaft |
Human antibodies that bind human TNFα
|
|
US5743909A
(en)
*
|
1996-06-24 |
1998-04-28 |
Collette; Michel |
Radiological method for preoperative determination of isometric attachment points of an ACL graft, surgical aiming instrument and method of use
|
|
CA2288430C
(en)
|
1997-04-16 |
2013-04-09 |
Millennium Biotherapeutics, Inc. |
Crsp protein (cysteine-rich secreted proteins), nucleic acid molecules encoding them and uses therefor
|
|
DE19752854C2
(de)
*
|
1997-11-28 |
2000-07-06 |
Bundesrepublik Deutschland Let |
Zellspezifische retrovirale Vektoren mit Antikörperdomänen und Verfahren zu ihrer Herstellung für den selektiven Gentransfer
|
|
US7056517B2
(en)
|
1998-04-13 |
2006-06-06 |
The Forsyth Institute |
Glucosyltransferase immunogens
|
|
US7163682B2
(en)
|
1998-04-13 |
2007-01-16 |
The Forsyth Institute |
Glucan binding protein and glucosyltransferase immunogens
|
|
EP1950295A1
(en)
*
|
1998-05-13 |
2008-07-30 |
Domantis Limited |
Phage display selection system for helper phages sensitive to proteolysis
|
|
US6420110B1
(en)
|
1998-10-19 |
2002-07-16 |
Gpc Biotech, Inc. |
Methods and reagents for isolating biologically active peptides
|
|
WO2000050443A2
(en)
|
1999-02-26 |
2000-08-31 |
Millennium Pharmaceutcals, Inc. |
Secreted proteins and uses thereof
|
|
CN100439399C
(zh)
|
1999-03-25 |
2008-12-03 |
艾博特股份有限两合公司 |
结合人il-12的人抗体及其生产方法
|
|
DE19915057A1
(de)
|
1999-04-01 |
2000-10-19 |
Forschungszentrum Borstel |
Monoklonale Antikörper gegen das humane Mcm3 Protein, Verfahren zu ihrer Herstellung und ihre Verwendung
|
|
US6472147B1
(en)
|
1999-05-25 |
2002-10-29 |
The Scripps Research Institute |
Methods for display of heterodimeric proteins on filamentous phage using pVII and pIX, compositions, vectors and combinatorial libraries
|
|
US20040001826A1
(en)
|
1999-06-30 |
2004-01-01 |
Millennium Pharmaceuticals, Inc. |
Glycoprotein VI and uses thereof
|
|
US7291714B1
(en)
|
1999-06-30 |
2007-11-06 |
Millennium Pharmaceuticals, Inc. |
Glycoprotein VI and uses thereof
|
|
WO2001014557A1
(en)
|
1999-08-23 |
2001-03-01 |
Dana-Farber Cancer Institute, Inc. |
Pd-1, a receptor for b7-4, and uses therefor
|
|
WO2001049717A2
(en)
|
1999-12-30 |
2001-07-12 |
President And Fellows Of Harvard College |
Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or t cell subset activity by modulation of xbp-1 activity
|
|
SK12942002A3
(sk)
|
2000-02-10 |
2003-05-02 |
Abbott Laboratories |
Protilátky viažuce ľudský interleukín-18, spôsoby ich výroby a použitia
|
|
EP1714661A3
(en)
|
2000-05-19 |
2012-03-14 |
The Center for Blood Research, INC. |
Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity
|
|
CA2410458A1
(en)
|
2000-06-08 |
2001-12-13 |
The Center For Blood Research, Inc. |
Methods and compositions for inhibiting immunoglobulin-mediated__reperfusion injury
|
|
NZ543512A
(en)
|
2000-06-28 |
2008-12-24 |
Genetics Inst Llc |
Interaction of PD-L2 with PD-1 transmits a negative signal to immune cells, downregulating immune responses
|
|
WO2002028893A2
(en)
|
2000-07-14 |
2002-04-11 |
Cropdesign N.V. |
Plant cyclin-dependent kinase inhibitors
|
|
JP2004515233A
(ja)
|
2000-11-01 |
2004-05-27 |
イルーシス セラポーティクス，インコーポレーテッド |
タンパク質トランススプライシングによる二重特異性分子の作製方法
|
|
JP2004526426A
(ja)
|
2000-11-28 |
2004-09-02 |
ワイス |
前立腺癌の診断および治療に有用なｋｉａａ核酸およびポリペプチドの発現分析
|
|
US6821731B2
(en)
|
2000-11-28 |
2004-11-23 |
Wyeth |
Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis of prostate cancer
|
|
AU2002231368C1
(en)
|
2001-01-05 |
2018-08-16 |
Amgen Fremont Inc. |
Antibodies to insulin-like growth factor I receptor
|
|
US7015047B2
(en)
*
|
2001-01-26 |
2006-03-21 |
Aviva Biosciences Corporation |
Microdevices having a preferential axis of magnetization and uses thereof
|
|
US7811768B2
(en)
|
2001-01-26 |
2010-10-12 |
Aviva Biosciences Corporation |
Microdevice containing photorecognizable coding patterns and methods of using and producing the same
|
|
US7323327B2
(en)
|
2001-02-23 |
2008-01-29 |
Dsm Ip Assets B.V. |
Genes encoding novel proteolytic enzymes
|
|
US20030165873A1
(en)
|
2001-03-02 |
2003-09-04 |
Come Jon H. |
Three hybrid assay system
|
|
EP1379125A4
(en)
|
2001-03-22 |
2004-12-08 |
Abbott Gmbh & Co Kg |
TRANSGENIC ANIMALS THAT EXPRESS SPECIFIC ANTIBODIES FOR INTERESTING GENES AND THEIR USE
|
|
EP1383912A4
(en)
|
2001-04-02 |
2007-11-28 |
Wyeth Corp |
PD-1, B7-4 RECEPTOR, AND ITS USES
|
|
EP2277897A1
(en)
|
2001-04-16 |
2011-01-26 |
Wyeth Holdings Corporation |
Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
|
|
CA2868614A1
(en)
|
2001-06-08 |
2002-12-08 |
Abbott Laboratories (Bermuda) Ltd. |
Methods of administering anti-tnf.alpha. antibodies
|
|
EP2270184A3
(en)
|
2001-06-22 |
2012-04-11 |
Pioneer Hi-Bred International, Inc. |
Defensin polynucleotides and methods of use
|
|
DE10135039C1
(de)
*
|
2001-07-18 |
2003-03-13 |
Nemod Immuntherapie Ag |
Verfahren zur Isolierung großer Varianzen spezifischer Moleküle für ein Zielmolekül aus Phagemid-Gen-Bibliotheken
|
|
US6833441B2
(en)
*
|
2001-08-01 |
2004-12-21 |
Abmaxis, Inc. |
Compositions and methods for generating chimeric heteromultimers
|
|
US20040142325A1
(en)
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
|
WO2003035842A2
(en)
*
|
2001-10-24 |
2003-05-01 |
Dyax Corporation |
Hybridization control of sequence variation
|
|
US7175983B2
(en)
*
|
2001-11-02 |
2007-02-13 |
Abmaxis, Inc. |
Adapter-directed display systems
|
|
AR039067A1
(es)
|
2001-11-09 |
2005-02-09 |
Pfizer Prod Inc |
Anticuerpos para cd40
|
|
US7858297B2
(en)
|
2001-12-18 |
2010-12-28 |
Centre National De La Recherche Scientifique Cnrs |
Chemokine-binding protein and methods of use
|
|
ES2337989T3
(es)
|
2001-12-18 |
2010-05-03 |
Endocube Sas |
Nuevas proteinas asociadas a la muerte de la familia thap y rutas par4 relacionadas implicadas en el control de la apoptosis.
|
|
EP1463807A4
(en)
|
2001-12-19 |
2006-04-12 |
Bristol Myers Squibb Co |
FORMATHYDROGENASE FROM PICHIA PASTORIS AND USES THEREOF
|
|
JP2005531511A
(ja)
|
2002-03-07 |
2005-10-20 |
ザ フォーシス インスティチュート |
グルカン結合タンパク質の免疫原性
|
|
US7214427B2
(en)
*
|
2002-03-21 |
2007-05-08 |
Aviva Biosciences Corporation |
Composite beads comprising magnetizable substance and electro-conductive substance
|
|
US7745192B2
(en)
|
2002-04-03 |
2010-06-29 |
Venomics Pty Limited |
Prothrombin activating protein
|
|
US20030206898A1
(en)
|
2002-04-26 |
2003-11-06 |
Steven Fischkoff |
Use of anti-TNFalpha antibodies and another drug
|
|
EA008607B1
(ru)
|
2002-05-21 |
2007-06-29 |
ДСМ Ай Пи ЭССЕТС Б.В. |
Полинуклеотид, кодирующий фосфолипазу aspergillus niger, фосфолипаза aspergillus niger и способы получения и применения полинуклеотида и фосфолипазы
|
|
WO2003106640A2
(en)
*
|
2002-06-14 |
2003-12-24 |
Case Western Reserve University |
Cell targeting methods and compositions
|
|
USRE47770E1
(en)
|
2002-07-18 |
2019-12-17 |
Merus N.V. |
Recombinant production of mixtures of antibodies
|
|
ATE514717T1
(de)
|
2002-07-18 |
2011-07-15 |
Merus B V |
Rekombinante produktion von antikörpermischungen
|
|
MY151032A
(en)
|
2002-07-19 |
2014-03-31 |
Abbott Lab S A |
Treatment of tnf? related disorders
|
|
US7250551B2
(en)
|
2002-07-24 |
2007-07-31 |
President And Fellows Of Harvard College |
Transgenic mice expressing inducible human p25
|
|
EA200500330A1
(ru)
|
2002-08-10 |
2006-06-30 |
Йейл Юниверсити |
Антагонисты nogo рецепторов
|
|
WO2004018660A2
(en)
|
2002-08-19 |
2004-03-04 |
Dsm Ip Assets B.V. |
Novel lipases and uses thereof
|
|
WO2004018505A1
(en)
|
2002-08-20 |
2004-03-04 |
Yeda Research And Development Co. Ltd. |
Akap84 and its use for visualization of biological structures
|
|
CN101044247B
(zh)
|
2002-08-20 |
2011-06-22 |
千年药品公司 |
用于鉴定,评估,预防和治疗子宫颈癌的组合物,试剂盒及方法
|
|
EP1536820B2
(en)
|
2002-09-04 |
2013-10-23 |
Biopolymer Engineering, Inc. |
Cancer therapy using whole glucan particles and antibodies
|
|
US20050054054A1
(en)
*
|
2002-11-12 |
2005-03-10 |
Foss Francine M. |
Interleukin-7 molecules with altered biological properties
|
|
AU2003302470A1
(en)
*
|
2002-11-26 |
2004-06-18 |
Dyax Corporation |
Methods and compositions for controlling valency of phage display
|
|
AU2004204095B2
(en)
|
2003-01-07 |
2009-07-30 |
Dyax Corporation |
Kunitz domain library
|
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
|
US20040180387A1
(en)
|
2003-03-13 |
2004-09-16 |
Fujirebio Diagnostics, Inc. |
Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of ovarian cancer
|
|
US20050014932A1
(en)
|
2003-05-15 |
2005-01-20 |
Iogenetics, Llc |
Targeted biocides
|
|
US20100069614A1
(en)
|
2008-06-27 |
2010-03-18 |
Merus B.V. |
Antibody producing non-human mammals
|
|
ES2408582T3
(es)
|
2003-05-30 |
2013-06-21 |
Merus B.V. |
Biblioteca de Fab para la preparación de una mezcla de anticuerpos
|
|
CA2542232A1
(en)
|
2003-06-09 |
2005-01-20 |
Alnylam Pharmaceuticals, Inc. |
Method for treating neurodegenerative disease by inhibiting alpha-synuclein
|
|
HN2004000285A
(es)
|
2003-08-04 |
2006-04-27 |
Pfizer Prod Inc |
ANTICUERPOS DIRIGIDOS A c-MET
|
|
AR045563A1
(es)
|
2003-09-10 |
2005-11-02 |
Warner Lambert Co |
Anticuerpos dirigidos a m-csf
|
|
CA2761987A1
(en)
|
2003-10-07 |
2005-04-21 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
|
|
US20050100965A1
(en)
|
2003-11-12 |
2005-05-12 |
Tariq Ghayur |
IL-18 binding proteins
|
|
US7968684B2
(en)
|
2003-11-12 |
2011-06-28 |
Abbott Laboratories |
IL-18 binding proteins
|
|
DOP2005000002A
(es)
|
2004-01-09 |
2005-08-15 |
Pfizer |
"anticuerpos contra madcam"
|
|
DK1737971T3
(da)
|
2004-01-20 |
2017-11-13 |
Merus Nv |
Blandinger af bindingsproteiner
|
|
US20060014211A1
(en)
|
2004-01-21 |
2006-01-19 |
Fujirebio Diagnostics, Inc. |
Detection of mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of the peritoneum and the peritoneal cavity
|
|
US7442783B2
(en)
|
2004-03-01 |
2008-10-28 |
The Cbr Institute For Biomedical Research, Inc. |
Natural IgM antibodies and inhibitors thereof
|
|
KR20080075045A
(ko)
|
2004-03-24 |
2008-08-13 |
트리패스 이미징, 인코포레이티드 |
자궁경부 질환의 검사 방법 및 조성물
|
|
TWI439284B
(zh)
|
2004-04-09 |
2014-06-01 |
Abbvie Biotechnology Ltd |
用於治療ＴＮＦα相關失調症之多重可變劑量療法
|
|
EP2270034A3
(en)
|
2004-06-03 |
2011-06-01 |
Athlomics Pty Ltd |
Agents and methods for diagnosing stress
|
|
GB0414054D0
(en)
|
2004-06-23 |
2004-07-28 |
Owen Mumford Ltd |
Improvements relating to automatic injection devices
|
|
EP2322215A3
(en)
|
2004-07-16 |
2011-09-28 |
Pfizer Products Inc. |
Combination treatment for non-hematologic malignancies using an anti-IGF-1R antibody
|
|
US7342093B2
(en)
|
2004-07-23 |
2008-03-11 |
University Of Massachusetts |
Compounds that inhibit Hsp90 protein-protein interactions with IAP proteins
|
|
EP1623996A1
(en)
*
|
2004-08-06 |
2006-02-08 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Improved method of selecting a desired protein from a library
|
|
ATE464382T1
(de)
*
|
2005-01-10 |
2010-04-15 |
Medimmune Ltd |
Mutageneseverfahren
|
|
GB0500417D0
(en)
|
2005-01-10 |
2005-02-16 |
Cambridge Antibody Tech |
Method of mutagenesis
|
|
GT200600031A
(es)
|
2005-01-28 |
2006-08-29 |
|
Formulacion anticuerpo anti a beta
|
|
NZ586780A
(en)
|
2005-03-23 |
2012-02-24 |
Genmab As |
Antibodies against CD38 for treatment of multiple myeloma
|
|
AR053067A1
(es)
|
2005-04-25 |
2007-04-18 |
Pfizer |
Anticuerpos contra miostatina
|
|
EP2444419A1
(en)
|
2005-04-26 |
2012-04-25 |
Pfizer Inc. |
P-Cadherin antibodies
|
|
US7595380B2
(en)
|
2005-04-27 |
2009-09-29 |
Tripath Imaging, Inc. |
Monoclonal antibodies and methods for their use in the detection of cervical disease
|
|
CN101500607B
(zh)
|
2005-05-16 |
2013-11-27 |
阿布维生物技术有限公司 |
TNFα抑制剂治疗腐蚀性多关节炎的用途
|
|
MX2007014474A
(es)
|
2005-05-17 |
2008-02-07 |
Univ Connecticut |
Composiciones y metodos para inmunomodulacion en un organismo.
|
|
CN103242447B
(zh)
|
2005-05-27 |
2016-04-27 |
比奥根Ma公司 |
结合tweak的抗体
|
|
MY144484A
(en)
|
2005-06-17 |
2011-09-30 |
Wyeth Corp |
Methods of purifying anti a beta antibodies
|
|
KR20130080058A
(ko)
|
2005-06-30 |
2013-07-11 |
아보트 러보러터리즈 |
Ｉｌ-12/ｐ40 결합 단백질
|
|
EP2476761A3
(en)
|
2005-07-07 |
2012-10-17 |
Athlomics Pty Ltd |
Polynucleotide marker genes and their expression, for diagnosis of endotoxemia
|
|
GB2428293A
(en)
*
|
2005-07-13 |
2007-01-24 |
Domantis Ltd |
Phage display libraries
|
|
CN109187944A
(zh)
|
2005-08-02 |
2019-01-11 |
埃克斯生物科技公司 |
使用IL-1α自身抗体诊断、治疗和预防血管疾病
|
|
CA2618482C
(en)
|
2005-08-19 |
2014-10-07 |
Abbott Laboratories |
Dual variable domain immunoglobin and uses thereof
|
|
EP2500359A3
(en)
|
2005-08-19 |
2012-10-17 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
US20070041905A1
(en)
|
2005-08-19 |
2007-02-22 |
Hoffman Rebecca S |
Method of treating depression using a TNF-alpha antibody
|
|
ZA200802971B
(en)
|
2005-09-07 |
2009-10-28 |
Amgen Fremont Inc |
Human monoclonal antibodies to activin receptor-like kinase-1
|
|
JP2009510002A
(ja)
|
2005-09-30 |
2009-03-12 |
アボット ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト |
反発誘導分子（ｒｇｍ）タンパク質ファミリーのタンパク質の結合ドメイン、及びその機能的断片、及びそれらの使用
|
|
US8597646B2
(en)
|
2005-10-25 |
2013-12-03 |
The Johns Hopkins University |
Methods and compositons featuring TGF-beta antagonists for the treatment of marfan syndrome and associated disorders
|
|
AU2006337105B2
(en)
|
2005-11-01 |
2013-05-02 |
Abbvie Biotechnology Ltd |
Methods and compositions for diagnosing ankylosing spondylitis using biomarkers
|
|
EP1949109B1
(en)
|
2005-11-14 |
2012-02-29 |
MetaMol Theranostics, LLC |
Peptide sequence that promotes tumor invasion
|
|
JP5486808B2
(ja)
|
2005-11-30 |
2014-05-07 |
アッヴィ・インコーポレイテッド |
アミロイドベータタンパク質に対するモノクローナル抗体及びその使用
|
|
BRPI0619249A2
(pt)
|
2005-11-30 |
2011-09-20 |
Abbott Lab |
anticorpos anti-globulÈmeros-aß, frações que se ligam a antìgeno destes, hibridomas correspondentes, ácidos nucléicos, vetores, células hospedeiras, métodos de produzir os ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos de usar os ditos anticorpos
|
|
AU2006350038B2
(en)
|
2005-11-30 |
2011-09-15 |
Massachusetts Institute Of Technology |
Pathogen detection biosensor
|
|
US10183986B2
(en)
|
2005-12-15 |
2019-01-22 |
Industrial Technology Research Institute |
Trimeric collagen scaffold antibodies
|
|
US8014957B2
(en)
|
2005-12-15 |
2011-09-06 |
Fred Hutchinson Cancer Research Center |
Genes associated with progression and response in chronic myeloid leukemia and uses thereof
|
|
US20070264687A1
(en)
|
2005-12-15 |
2007-11-15 |
Min-Yuan Chou |
Recombinant triplex scaffold-based polypeptides
|
|
US7632498B2
(en)
|
2005-12-19 |
2009-12-15 |
Tripath Imaging, Inc. |
MCM6 and MCM7 monoclonal antibodies and methods for their use in the detection of cervical disease
|
|
BRPI0707276B1
(pt)
|
2006-01-27 |
2021-08-31 |
Biogen Ma Inc |
Polipeptídeo de fusão antagonista de receptor nogo
|
|
EP1987360B1
(en)
|
2006-01-27 |
2012-03-07 |
Tripath Imaging, Inc. |
Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor
|
|
TWI417301B
(zh)
|
2006-02-21 |
2013-12-01 |
Wyeth Corp |
對抗人類介白素-２２（ｉｌ-２２）之抗體及其用途
|
|
TW200744634A
(en)
|
2006-02-21 |
2007-12-16 |
Wyeth Corp |
Methods of using antibodies against human IL-22
|
|
WO2007100711A2
(en)
*
|
2006-02-24 |
2007-09-07 |
Investigen, Inc. |
Methods and compositions for detecting polynucleotides
|
|
EP2010569A4
(en)
|
2006-03-20 |
2009-09-09 |
Xoma Technology Ltd |
HUMAN ANTIBODIES SPECIFIC TO GASTRINE MATERIALS AND METHODS
|
|
EP2738179A1
(en)
|
2006-04-05 |
2014-06-04 |
AbbVie Biotechnology Ltd |
Antibody purification
|
|
EP2007426A4
(en)
|
2006-04-10 |
2010-06-16 |
Abbott Biotech Ltd |
COMPOSITIONS FOR THE TREATMENT OF PSORIASTIC POLYARTHRITIS AND THEIR APPLICATIONS
|
|
CA2564435A1
(en)
|
2006-04-10 |
2007-10-10 |
Abbott Biotechnology Ltd. |
Methods for monitoring and treating intestinal disorders
|
|
EP2703010A3
(en)
|
2006-04-10 |
2014-08-06 |
AbbVie Biotechnology Ltd |
Uses and compositions for treatment of rheumatoid arthritis
|
|
US10522240B2
(en)
|
2006-05-03 |
2019-12-31 |
Population Bio, Inc. |
Evaluating genetic disorders
|
|
US7702468B2
(en)
|
2006-05-03 |
2010-04-20 |
Population Diagnostics, Inc. |
Evaluating genetic disorders
|
|
NZ572765A
(en)
|
2006-06-30 |
2012-08-31 |
Abbott Biotech Ltd |
Automatic injection device with rod driving syringe longitudinally split with radially compressible pair of wings along its length
|
|
EP2402437B1
(en)
|
2006-07-05 |
2016-06-01 |
Catalyst Biosciences, Inc. |
Protease screening methods and proteases identified thereby
|
|
ES2613957T3
(es)
|
2006-08-04 |
2017-05-29 |
Medimmune Limited |
Anticuerpos contra ERBB2
|
|
EP3910065B1
(en)
|
2006-09-08 |
2025-07-23 |
AbbVie Bahamas Ltd. |
Interleukin -13 binding proteins
|
|
TR201910145T4
(tr)
|
2006-09-26 |
2019-08-21 |
Genmab As |
Tümörlerin tedavi edilmesine yönelik anti-CD38 artı kortikosteroidler artı bir kortikosteroid-olmayan kemoterapötik.
|
|
BRPI0719250A2
(pt)
|
2006-10-12 |
2015-06-16 |
Wyeth Corp |
Métodos e composições com opalescência reduzida.
|
|
US20080096193A1
(en)
*
|
2006-10-24 |
2008-04-24 |
Charles Robert Bupp |
Methods and compositions for detecting polynucleotides
|
|
WO2008055260A2
(en)
|
2006-11-03 |
2008-05-08 |
Wyeth |
Glycolysis-inhibiting substances in cell culture
|
|
EP2094282A4
(en)
|
2006-11-15 |
2010-05-05 |
Functional Genetics Inc |
ANTI-TSG101 ANTIBODIES AND USES THEREOF FOR THE TREATMENT OF VIRAL INFECTIONS
|
|
US7488807B2
(en)
|
2006-11-22 |
2009-02-10 |
3M Innovative Properties Company |
Antibody with protein A selectivity
|
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
|
NZ577805A
(en)
|
2006-12-05 |
2012-09-28 |
Decode Genetics Ehf |
Genetic markers for risk management of cardiac arrhythmia
|
|
EP2094306A2
(en)
|
2006-12-20 |
2009-09-02 |
XOMA Technology Ltd. |
Treatment of il-1-beta related diseases
|
|
CA2947292C
(en)
|
2006-12-27 |
2019-07-23 |
Emory University |
Compositions and methods for the treatment of infections and tumors
|
|
US7776331B1
(en)
|
2007-01-16 |
2010-08-17 |
Abbott Laboratories |
Methods of treating plaque psoriasis
|
|
US8664364B2
(en)
|
2007-01-24 |
2014-03-04 |
Carnegie Mellon University |
Optical biosensors
|
|
MX2009008461A
(es)
|
2007-02-07 |
2009-08-17 |
Decode Genetics Ehf |
Variantes geneticas que contribuyen a riesgo de cancer de prostata.
|
|
JP5646179B2
(ja)
|
2007-02-21 |
2014-12-24 |
デコード・ジェネティクス・イーエイチエフ |
循環器疾患に関連する遺伝的感受性変異体
|
|
WO2008103702A2
(en)
*
|
2007-02-23 |
2008-08-28 |
Investigen, Inc. |
Methods and compositions for rapid light-activated isolation and detection of analytes
|
|
EP2486928A1
(en)
|
2007-02-27 |
2012-08-15 |
Abbott GmbH & Co. KG |
Method for the treatment of amyloidoses
|
|
ES2381780T3
(es)
|
2007-03-22 |
2012-05-31 |
Heptares Therapeutics Limited |
Receptores acoplados a proteínas G mutantes y métodos para seleccionarlos
|
|
CA2682927A1
(en)
|
2007-04-02 |
2008-10-16 |
Amgen Fremont Inc. |
Anti-ige antibodies
|
|
EP2147096B1
(en)
|
2007-04-13 |
2015-03-25 |
Catalyst Biosciences, Inc. |
Modified factor VII polypeptides and uses thereof
|
|
TW200902708A
(en)
|
2007-04-23 |
2009-01-16 |
Wyeth Corp |
Methods of protein production using anti-senescence compounds
|
|
AU2008256219B2
(en)
|
2007-05-25 |
2014-06-05 |
Decode Genetics Ehf. |
Genetic variants on Chr 5p12 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
|
|
EP2171451A4
(en)
|
2007-06-11 |
2011-12-07 |
Abbott Biotech Ltd |
METHOD FOR TREATING JUVENILIAN IDIOPATHIC ARTHRITIS
|
|
PT2170956E
(pt)
|
2007-06-15 |
2015-02-05 |
Medigene Ag |
Tratamento de tumores utilizando um anticorpo anti-l1 específico
|
|
US8697360B2
(en)
|
2007-11-30 |
2014-04-15 |
Decode Genetics Ehf. |
Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition
|
|
US8426153B2
(en)
|
2007-12-03 |
2013-04-23 |
Carnegie Mellon University |
Linked peptides fluorogenic biosensors
|
|
GB0724051D0
(en)
|
2007-12-08 |
2008-01-16 |
Medical Res Council |
Mutant proteins and methods for producing them
|
|
GB0724860D0
(en)
|
2007-12-20 |
2008-01-30 |
Heptares Therapeutics Ltd |
Screening
|
|
JP5536666B2
(ja)
|
2007-12-20 |
2014-07-02 |
ゾーマ （ユーエス） リミテッド ライアビリティ カンパニー |
痛風の治療のための方法
|
|
JP5730020B2
(ja)
|
2007-12-28 |
2015-06-03 |
ネオトープ バイオサイエンシーズ リミテッド |
アミロイドーシスの処置および予防
|
|
GB0802474D0
(en)
|
2008-02-11 |
2008-03-19 |
Heptares Therapeutics Ltd |
Mutant proteins and methods for selecting them
|
|
AU2009213689B2
(en)
|
2008-02-14 |
2014-11-20 |
Decode Genetics Ehf. |
Susceptibility variants for lung cancer
|
|
JP2011512817A
(ja)
|
2008-02-28 |
2011-04-28 |
スリーエム イノベイティブ プロパティズ カンパニー |
クロストリジウム・ディフィシル胞子に対する抗体及びその使用
|
|
US8962803B2
(en)
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
|
US8178092B2
(en)
|
2008-03-18 |
2012-05-15 |
Abbott Laboratories |
Methods of treating psoriasis by administration of antibodies to the p40 subunit of IL-12 and/or IL-23
|
|
EP2274450A2
(en)
|
2008-04-01 |
2011-01-19 |
Decode Genetics EHF |
Susceptibility variants for peripheral arterial disease and abdominal aortic aneurysm
|
|
SG10202105499WA
(en)
|
2008-04-25 |
2021-07-29 |
Dyax Corp |
Antibodies Against Fcrn And Use Thereof
|
|
US20100260668A1
(en)
*
|
2008-04-29 |
2010-10-14 |
Abbott Laboratories |
Dual Variable Domain Immunoglobulins and Uses Thereof
|
|
CA2722466A1
(en)
|
2008-04-29 |
2009-11-05 |
Tariq Ghayur |
Dual variable domain immunoglobulins and uses thereof
|
|
CA2723219A1
(en)
|
2008-05-09 |
2009-11-12 |
Abbott Gmbh & Co. Kg |
Antibodies to receptor of advanced glycation end products (rage) and uses thereof
|
|
BRPI0913406A2
(pt)
|
2008-06-03 |
2018-01-09 |
Abbott Lab |
imunoglobulinas de domínio variável duplo e usos das mesmas
|
|
JP5723769B2
(ja)
|
2008-06-03 |
2015-05-27 |
アッヴィ・インコーポレイテッド |
二重可変ドメイン免疫グロブリン及びその使用
|
|
AU2009269542A1
(en)
|
2008-07-07 |
2010-01-14 |
Decode Genetics Ehf |
Genetic variants for breast cancer risk assessment
|
|
CN102143760B
(zh)
|
2008-07-08 |
2015-06-17 |
Abbvie公司 |
前列腺素e2结合蛋白及其用途
|
|
WO2010006060A2
(en)
|
2008-07-08 |
2010-01-14 |
Abbott Laboratories |
Prostaglandin e2 dual variable domain immunoglobulins and uses thereof
|
|
WO2010005570A2
(en)
|
2008-07-09 |
2010-01-14 |
Biogen Idec Ma Inc. |
Compositions comprising antibodies to lingo or fragments thereof
|
|
US20110189186A1
(en)
*
|
2008-08-28 |
2011-08-04 |
The Uab Research Foundation |
Affecting bone related conditions using cd68 blocking agents
|
|
US9023594B2
(en)
|
2008-09-05 |
2015-05-05 |
President And Fellows Of Harvard College |
Continuous directed evolution of proteins and nucleic acids
|
|
AU2009293640A1
(en)
*
|
2008-09-22 |
2010-03-25 |
Calmune Corporation |
Methods and vectors for display of 2G12 -derived domain exchanged antibodies
|
|
WO2010033237A2
(en)
*
|
2008-09-22 |
2010-03-25 |
Calmune Corporation |
Methods for creating diversity in libraries and libraries, display vectors and methods, and displayed molecules
|
|
US20100075329A1
(en)
|
2008-09-23 |
2010-03-25 |
O'toole Margot |
Methods for predicting production of activating signals by cross-linked binding proteins
|
|
EP2352841A2
(en)
|
2008-09-23 |
2011-08-10 |
President and Fellows of Harvard College |
Sirt4 and uses thereof
|
|
US8313942B2
(en)
|
2008-09-26 |
2012-11-20 |
Wyeth Llc |
Compatible display vector systems
|
|
EP3133086B1
(en)
|
2008-09-26 |
2018-08-01 |
Dana-Farber Cancer Institute, Inc. |
Human anti-pd-1, pd-l1, and pd-l2 antibodies and uses thereof
|
|
SMT202000101T1
(it)
|
2008-10-10 |
2020-03-13 |
Childrens Medical Center |
Vaccino con trimero di env di hiv-1 stabilizzato biochimicamente
|
|
JP2012505900A
(ja)
|
2008-10-14 |
2012-03-08 |
ダイアクス コーポレーション |
全身性強皮症に伴う肺線維症の治療および予防のためのｉｇｆ−ｉｉ／ｉｇｆ−ｉｉｅ結合タンパク質の使用
|
|
EP2921501A1
(en)
|
2008-10-20 |
2015-09-23 |
Abbvie Inc. |
Isolation and purification of antibodies using Protein A affinity chromatography
|
|
CN105646643A
(zh)
|
2008-10-29 |
2016-06-08 |
阿布林克斯公司 |
单域抗原结合性分子的纯化方法
|
|
AU2009333791B2
(en)
|
2008-10-29 |
2013-04-04 |
Ablynx N.V. |
Formulations of single domain antigen binding molecules
|
|
DK2346904T3
(da)
|
2008-10-29 |
2017-06-12 |
China Synthetic Rubber Corp |
Fremgangsmåder og midler til diagnosen og behandling af hepatocellular carcinom
|
|
EP2361093A2
(en)
|
2008-11-26 |
2011-08-31 |
Five Prime Therapeutics, Inc. |
Compositions and methods for regulating collagen and smooth muscle actin expression by serpine2
|
|
US9598491B2
(en)
|
2008-11-28 |
2017-03-21 |
Emory University |
Methods for the treatment of infections and tumors
|
|
KR20110097913A
(ko)
*
|
2008-12-04 |
2011-08-31 |
아보트 러보러터리즈 |
이원 가변 도메인 면역글로불린 및 이의 용도
|
|
US9181315B2
(en)
|
2009-01-08 |
2015-11-10 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for induced brown fat differentiation
|
|
EP2398860B1
(en)
|
2009-02-18 |
2013-11-20 |
Carnegie Mellon University |
Quenched dendrimeric dyes for fluorescence detection
|
|
US8030026B2
(en)
|
2009-02-24 |
2011-10-04 |
Abbott Laboratories |
Antibodies to troponin I and methods of use thereof
|
|
EP2403880A1
(en)
|
2009-03-05 |
2012-01-11 |
Tripath Imaging, Inc. |
Matrix metalloproteinase-7 (mmp-7) monoclonal antibodies and methods for their use in the detection of ovarian cancer
|
|
SG173705A1
(en)
|
2009-03-05 |
2011-09-29 |
Abbott Lab |
Il-17 binding proteins
|
|
CA2753713A1
(en)
|
2009-03-06 |
2010-09-10 |
Tripath Imaging, Inc |
Glycodelin monoclonal antibodies and methods for their use in the detection of ovarian cancer
|
|
AU2010231494B2
(en)
|
2009-04-03 |
2016-01-07 |
Decode Genetics Ehf |
Genetic markers for risk management of atrial fibrillation and stroke
|
|
US8765916B2
(en)
|
2009-04-29 |
2014-07-01 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
ERG monoclonal antibodies
|
|
US8636704B2
(en)
|
2009-04-29 |
2014-01-28 |
Abbvie Biotechnology Ltd |
Automatic injection device
|
|
EP2432878B2
(en)
*
|
2009-05-20 |
2018-05-16 |
Novimmune SA |
Synthetic polypeptide libraries and methods for generating naturally diversified polypeptide variants
|
|
EP2261242A1
(en)
|
2009-06-10 |
2010-12-15 |
Universite Catholique De Louvain |
Aspartate-N-acetyltransferase enzyme, diagnostic method and therapeutic method
|
|
GB0910725D0
(en)
|
2009-06-22 |
2009-08-05 |
Heptares Therapeutics Ltd |
Mutant proteins and methods for producing them
|
|
EP2272979A1
(en)
|
2009-06-30 |
2011-01-12 |
Centre National de la Recherche Scientifique (CNRS) |
Method for testing a subject thought to be predisposed to having cancer
|
|
SG177583A1
(en)
|
2009-07-09 |
2012-02-28 |
Hoffmann La Roche |
In vivo tumor vasculature imaging
|
|
AU2010269841A1
(en)
|
2009-07-10 |
2012-02-23 |
Decode Genetics Ehf |
Genetic markers associated with risk of diabetes mellitus
|
|
TW201109438A
(en)
*
|
2009-07-29 |
2011-03-16 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
|
US9259476B2
(en)
|
2009-07-31 |
2016-02-16 |
Wayne State University |
Monophosphorylated lipid A derivatives
|
|
EP2287336A1
(fr)
|
2009-07-31 |
2011-02-23 |
Exhonit Therapeutics SA |
Procédés et méthodes de diagnostic de la maladie d'Alzheimer
|
|
US8809285B2
(en)
|
2009-07-31 |
2014-08-19 |
Wayne State University |
Monophosphorylated lipid A derivatives
|
|
MX336152B
(es)
|
2009-08-29 |
2016-01-08 |
Abbvie Inc |
Proteinas terapeutico de union a dll4.
|
|
AU2010289527C1
(en)
|
2009-09-01 |
2014-10-30 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
|
US20110189183A1
(en)
|
2009-09-18 |
2011-08-04 |
Robert Anthony Williamson |
Antibodies against candida, collections thereof and methods of use
|
|
US8926976B2
(en)
|
2009-09-25 |
2015-01-06 |
Xoma Technology Ltd. |
Modulators
|
|
AU2010298025B2
(en)
|
2009-09-25 |
2016-04-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Neutralizing antibodies to HIV-1 and their use
|
|
CA2772945A1
(en)
|
2009-09-25 |
2011-03-31 |
Xoma Technology Ltd. |
Screening methods
|
|
WO2011041584A2
(en)
|
2009-09-30 |
2011-04-07 |
President And Fellows Of Harvard College |
Methods for modulation of autophagy through the modulation of autophagy-enhancing gene products
|
|
US8716450B2
(en)
|
2009-10-15 |
2014-05-06 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
|
MX341136B
(es)
|
2009-10-20 |
2016-08-09 |
Abbvie Inc |
Aislamiento y purificacion de los anticuerpos anti-il-13 al usar la cromatografia de afinidad con proteina a.
|
|
US20110098862A1
(en)
|
2009-10-27 |
2011-04-28 |
ExxonMobil Research Engineering Company Law Department |
Multi-stage processes and control thereof
|
|
UY32979A
(es)
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
US8420083B2
(en)
|
2009-10-31 |
2013-04-16 |
Abbvie Inc. |
Antibodies to receptor for advanced glycation end products (RAGE) and uses thereof
|
|
WO2011058087A1
(en)
|
2009-11-11 |
2011-05-19 |
Gentian As |
Immunoassay for assessing related analytes of different origin
|
|
WO2011060272A2
(en)
|
2009-11-13 |
2011-05-19 |
Dana-Farber Cancer Institute, Inc. |
Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1
|
|
EP2325311A1
(en)
|
2009-11-18 |
2011-05-25 |
Pierre Fabre Medicament |
Novel phage display vector
|
|
KR20120118002A
(ko)
|
2009-12-08 |
2012-10-25 |
애보트 게엠베하 운트 콤파니 카게 |
망막 신경 섬유 층 변성의 치료에 사용하기 위한 ｒｇｍ ａ 단백질에 대한 모노클로날 항체
|
|
DK3459564T3
(da)
|
2010-01-06 |
2022-02-07 |
Takeda Pharmaceuticals Co |
Plasmakallikreinbindende proteiner
|
|
WO2011088163A1
(en)
|
2010-01-14 |
2011-07-21 |
President And Fellows Of Harvard College |
Methods for modulating skeletal remodeling and patterning by modulating shn2 activity, shn3 activity, or shn2 and shn3 activity in combination
|
|
EP2526424A2
(en)
|
2010-01-22 |
2012-11-28 |
Dana-Farber Cancer Institute, Inc. |
Compositions,kits, and methods for identification, assessment, prevention, and therapy of metabolic disorders
|
|
WO2011097301A2
(en)
|
2010-02-02 |
2011-08-11 |
Abbott Biotechnology Ltd. |
METHODS AND COMPOSITIONS FOR PREDICTING RESPONSIVENESS TO TREATMENT WITH TNF-α INHIBITOR
|
|
TWI518325B
(zh)
|
2010-02-04 |
2016-01-21 |
自治醫科大學 |
對ａｌｋ抑制劑具有先抗性或後抗性癌症的識別、判斷和治療
|
|
AU2011223919B2
(en)
|
2010-03-02 |
2015-03-19 |
Abbvie Inc. |
Therapeutic DLL4 binding proteins
|
|
WO2013040142A2
(en)
|
2011-09-16 |
2013-03-21 |
Iogenetics, Llc |
Bioinformatic processes for determination of peptide binding
|
|
US10706955B2
(en)
|
2010-03-23 |
2020-07-07 |
Iogenetics, Llc |
Bioinformatic processes for determination of peptide binding
|
|
US8987419B2
(en)
|
2010-04-15 |
2015-03-24 |
AbbVie Deutschland GmbH & Co. KG |
Amyloid-beta binding proteins
|
|
DK2571532T3
(da)
|
2010-05-14 |
2017-08-28 |
Abbvie Inc |
Il-1-bindende proteiner
|
|
WO2011150079A1
(en)
|
2010-05-25 |
2011-12-01 |
Carnegie Mellon University |
Targeted probes of cellular physiology
|
|
HUE039740T2
(hu)
|
2010-06-03 |
2019-01-28 |
Abbvie Biotechnology Ltd |
Alkalmazások és készítmények hidradenitis suppurativa (HS) kezelésére
|
|
MX2012014838A
(es)
|
2010-06-16 |
2013-02-07 |
Abbvie Inc |
Comparacion de las muestras de proteina.
|
|
US20120009196A1
(en)
|
2010-07-08 |
2012-01-12 |
Abbott Laboratories |
Monoclonal antibodies against hepatitis c virus core protein
|
|
UY33492A
(es)
|
2010-07-09 |
2012-01-31 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
CA2805572A1
(en)
|
2010-07-16 |
2012-01-19 |
Martin Hegen |
Modified single domain antigen binding molecules and uses thereof
|
|
CN103392182B
(zh)
|
2010-08-02 |
2017-07-04 |
众有生物有限公司 |
用于发现遗传疾病中致病突变的系统和方法
|
|
EP2601218A4
(en)
|
2010-08-03 |
2015-02-18 |
Abbvie Inc |
VARIABLE DOUBLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF
|
|
WO2012019061A2
(en)
|
2010-08-05 |
2012-02-09 |
Stem Centrx, Inc. |
Novel effectors and methods of use
|
|
EP2420250A1
(en)
|
2010-08-13 |
2012-02-22 |
Universitätsklinikum Münster |
Anti-Syndecan-4 antibodies
|
|
JP6147665B2
(ja)
|
2010-08-14 |
2017-06-14 |
アッヴィ・インコーポレイテッド |
アミロイドベータ結合タンパク質
|
|
AU2011291462A1
(en)
|
2010-08-19 |
2013-03-14 |
Zoetis Belgium S.A. |
Anti-NGF antibodies and their use
|
|
TW201211252A
(en)
|
2010-08-26 |
2012-03-16 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
|
JP2013539468A
(ja)
|
2010-08-27 |
2013-10-24 |
ステム セントリックス， インコーポレイテッド |
Ｎｏｔｕｍタンパク質モジュレーターおよび使用法
|
|
KR20140014064A
(ko)
|
2010-09-03 |
2014-02-05 |
스템 센트알엑스 인코포레이티드 |
신규한 조절 인자 및 사용 방법
|
|
MX2013003182A
(es)
|
2010-09-20 |
2013-04-24 |
Abbvie Inc |
Purificacion de anticuerpos por cromatografia de lecho movil simulada.
|
|
WO2012044921A1
(en)
|
2010-10-01 |
2012-04-05 |
St. Jude Children's Research Hospital |
Methods and compositions for typing molecular subgroups of medulloblastoma
|
|
WO2012052391A1
(en)
|
2010-10-19 |
2012-04-26 |
Glaxo Group Limited |
Polypeptide with jmjd3 catalytic activity
|
|
WO2012068463A2
(en)
|
2010-11-18 |
2012-05-24 |
Beth Israel Deaconess Medicall Center, Inc. |
Methods of treating obesity by inhibiting nicotinamide n-methyl transferase (nnmt)
|
|
NZ611428A
(en)
|
2010-12-08 |
2015-07-31 |
Stemcentrx Inc |
Novel modulators and methods of use
|
|
CA2821976A1
(en)
|
2010-12-21 |
2012-09-13 |
Abbvie Inc. |
Il-1 -alpha and -beta bispecific dual variable domain immunoglobulins and their use
|
|
US20120275996A1
(en)
|
2010-12-21 |
2012-11-01 |
Abbott Laboratories |
IL-1 Binding Proteins
|
|
AU2011348204B2
(en)
|
2010-12-22 |
2017-03-02 |
President And Fellows Of Harvard College |
Continuous directed evolution
|
|
WO2012092323A1
(en)
|
2010-12-28 |
2012-07-05 |
Xoma Technology Ltd. |
Cell surface display using pdz domains
|
|
WO2012089814A1
(en)
|
2010-12-30 |
2012-07-05 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antigen binding formats for use in therapeutic treatments or diagnostic assays
|
|
BR112013018905B1
(pt)
|
2011-01-24 |
2021-07-13 |
Abbvie Biotechnology Ltd |
Dispositivos de injeção automática que têm superfícies de pega sobremoldadas.
|
|
WO2012109238A2
(en)
|
2011-02-07 |
2012-08-16 |
President And Fellows Of Harvard College |
Methods for increasing immune responses using agents that directly bind to and activate ire-1
|
|
SA112330278B1
(ar)
|
2011-02-18 |
2015-10-09 |
ستيم سينتركس، انك. |
مواد ضابطة جديدة وطرق للاستخدام
|
|
ES2777894T3
(es)
|
2011-03-02 |
2020-08-06 |
Berg Llc |
Ensayos por interrogación basados en células y usos de los mismos
|
|
WO2012122219A2
(en)
|
2011-03-07 |
2012-09-13 |
University Of Louisville Research Foundation |
Predictive marker of dnmt1 inhibitor therapeutic efficacy and methods of using the marker
|
|
WO2012125735A1
(en)
|
2011-03-15 |
2012-09-20 |
Abott Laboratories |
An integrated approach to the isolation and purification of antibodies
|
|
WO2012128810A1
(en)
|
2011-03-23 |
2012-09-27 |
Abbott Laboratories |
Methods and systems for the analysis of protein samples
|
|
WO2012131053A1
(en)
|
2011-03-30 |
2012-10-04 |
Ablynx Nv |
Methods of treating immune disorders with single domain antibodies against tnf-alpha
|
|
WO2012134813A1
(en)
|
2011-03-31 |
2012-10-04 |
St. Jude Children's Research Hospital |
Methods and compositions for identifying minimal residual disease in acute lymphoblastic leukemia
|
|
CA2832565A1
(en)
|
2011-04-08 |
2012-10-11 |
Biogen Idec Ma Inc. |
Biomarkers predictive of therapeutic responsiveness to ifn.beta. and uses thereof
|
|
WO2012142164A1
(en)
|
2011-04-12 |
2012-10-18 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Human monoclonal antibodies that bind insulin-like growth factor (igf) i and ii
|
|
CA2837527C
(en)
|
2011-06-02 |
2019-05-28 |
Dyax Corp. |
Fc receptor binding proteins
|
|
LT2714735T
(lt)
|
2011-06-03 |
2021-12-10 |
Xoma Technology Ltd. |
Tgf beta specifiniai antikūnai
|
|
JP2014520847A
(ja)
|
2011-07-13 |
2014-08-25 |
アッヴィ・インコーポレイテッド |
抗ｉｌ−１３抗体を使用して喘息を治療するための方法および組成物
|
|
AU2012298884B2
(en)
|
2011-08-23 |
2017-11-16 |
Foundation Medicine, Inc. |
Novel KIF5B-RET fusion molecules and uses thereof
|
|
US20130058947A1
(en)
|
2011-09-02 |
2013-03-07 |
Stem Centrx, Inc |
Novel Modulators and Methods of Use
|
|
WO2013034687A1
(en)
|
2011-09-09 |
2013-03-14 |
Universität Bern Verwaltungsdirektion |
Avibacterium paragallinarum rtx toxin
|
|
CA2848368C
(en)
|
2011-09-13 |
2023-02-14 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for brown fat induction and activity using fndc5
|
|
ES2656442T3
(es)
|
2011-09-19 |
2018-02-27 |
Axon Neuroscience Se |
Terapia basada en proteínas y diagnóstico de una patología mediada por tau en la enfermedad de Alzheimer
|
|
US10221454B2
(en)
|
2011-10-10 |
2019-03-05 |
The Hospital For Sick Children |
Methods and compositions for screening and treating developmental disorders
|
|
WO2013056178A2
(en)
|
2011-10-14 |
2013-04-18 |
Foundation Medicine, Inc. |
Novel estrogen receptor mutations and uses thereof
|
|
SG11201401791WA
(en)
|
2011-10-24 |
2014-08-28 |
Abbvie Inc |
Immunobinders directed against sclerostin
|
|
UY34409A
(es)
|
2011-10-24 |
2013-05-31 |
Abbvie Inc |
Inmunoenlazadores dirigidos contra el tnf
|
|
EP2773390B1
(en)
|
2011-11-03 |
2020-12-30 |
Tripath Imaging, Inc. |
Methods and compositions for preparing samples for immunostaining
|
|
EP2773779B1
(en)
|
2011-11-04 |
2020-10-14 |
Population Bio, Inc. |
Methods and compositions for diagnosing, prognosing, and treating neurological conditions
|
|
IN2014CN04183A
(da)
|
2011-11-08 |
2015-07-17 |
Pfizer |
|
|
US20140017174A1
(en)
|
2011-11-30 |
2014-01-16 |
Raja Atreya |
Methods and compositions for determining responsiveness to treatment with a tnf-alpha inhibitor
|
|
CN104136462B
(zh)
|
2011-12-14 |
2017-06-09 |
艾伯维德国有限责任两合公司 |
用于诊断和治疗铁相关病症的组合物和方法
|
|
JP6342812B2
(ja)
|
2011-12-14 |
2018-06-13 |
アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー |
鉄関連障害を診断および治療するための組成物および方法
|
|
EP3050900A1
(en)
|
2011-12-19 |
2016-08-03 |
Xoma (Us) Llc |
Methods for treating acne
|
|
AU2012362326A1
(en)
|
2011-12-30 |
2014-07-24 |
Abbvie Inc. |
Dual variable domain immunoglobulins against IL-13 and/or IL-17
|
|
RS57603B1
(sr)
|
2012-01-27 |
2018-11-30 |
Abbvie Deutschland |
Sastav i metod za dijagnozu i tretiranje bolesti povezanih sa degeneracijom neurita
|
|
CA2863887C
(en)
|
2012-02-09 |
2023-01-03 |
Population Diagnostics, Inc. |
Methods of screening low frequency gdna variation biomarkers for pervasive developmental disorder (pdd) or pervasive developmental disorder - not otherwise specified (pdd_nos)
|
|
ME02928B
(me)
|
2012-02-24 |
2018-04-20 |
Abbvie Stemcentrx Llc |
Dll3 modulatori i metode upotrebe
|
|
EA038600B1
(ru)
|
2012-04-02 |
2021-09-21 |
Берг Ллк |
Основанные на клетках перекрестные анализы и их применение
|
|
SI2838917T1
(sl)
|
2012-04-20 |
2019-11-29 |
Merus Nv |
Postopki in sredstva za produkcijo heterodimernih IG-podobnih molekul
|
|
WO2013158273A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Methods to modulate c-terminal lysine variant distribution
|
|
US9150645B2
(en)
|
2012-04-20 |
2015-10-06 |
Abbvie, Inc. |
Cell culture methods to reduce acidic species
|
|
WO2013158275A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Cell culture methods to reduce acidic species
|
|
HK1206252A1
(en)
|
2012-05-14 |
2016-01-08 |
Biogen Ma Inc. |
Lingo-2 antagonists for treatment of conditions involving motor neurons
|
|
US20130336957A1
(en)
|
2012-05-21 |
2013-12-19 |
Abbvie, Inc. |
Novel purification of human, humanized, or chimeric antibodies using protein a affinity chromatography
|
|
WO2013176754A1
(en)
|
2012-05-24 |
2013-11-28 |
Abbvie Inc. |
Novel purification of antibodies using hydrophobic interaction chromatography
|
|
EP2859018B1
(en)
|
2012-06-06 |
2021-09-22 |
Zoetis Services LLC |
Caninized anti-ngf antibodies and methods thereof
|
|
AR091755A1
(es)
|
2012-07-12 |
2015-02-25 |
Abbvie Inc |
Proteinas de union a il-1
|
|
US10457733B2
(en)
|
2012-08-03 |
2019-10-29 |
Dana-Farber Cancer Institute, Inc. |
Agents that modulate immune cell activation and methods of use thereof
|
|
WO2014039860A2
(en)
|
2012-09-07 |
2014-03-13 |
University Of Louisville Research Foundation, Inc. |
Compositions and methods for modulating dnmt1 inhibitor activity
|
|
EP2895621B1
(en)
|
2012-09-14 |
2020-10-21 |
Population Bio, Inc. |
Methods and compositions for diagnosing, prognosing, and treating neurological conditions
|
|
CA2922005A1
(en)
|
2012-09-27 |
2014-04-03 |
Population Diagnostics, Inc. |
Methods and compositions for screening and treating developmental disorders
|
|
AU2013329421A1
(en)
|
2012-10-09 |
2015-04-30 |
Biogen Ma Inc. |
Combination therapies and uses for treatment of demyelinating disorders
|
|
BR112015009961B1
(pt)
|
2012-11-01 |
2020-10-20 |
Abbvie Inc. |
proteína de ligação capaz de se ligar a dll4 e vegf, bem como composição que a compreende como composição que a compreende
|
|
WO2014071358A2
(en)
|
2012-11-05 |
2014-05-08 |
Foundation Medicine, Inc. |
Novel ntrk1 fusion molecules and uses thereof
|
|
WO2014074942A1
(en)
|
2012-11-08 |
2014-05-15 |
Illumina, Inc. |
Risk variants of alzheimer's disease
|
|
CN104903349B
(zh)
|
2012-11-08 |
2018-10-19 |
十一生物治疗股份有限公司 |
Il-6拮抗剂及其应用
|
|
AU2013359419B2
(en)
|
2012-12-10 |
2018-03-15 |
Biogen Ma Inc. |
Anti-blood dendritic cell antigen 2 antibodies and uses thereof
|
|
US9550986B2
(en)
|
2012-12-21 |
2017-01-24 |
Abbvie Inc. |
High-throughput antibody humanization
|
|
US10717965B2
(en)
|
2013-01-10 |
2020-07-21 |
Gloriana Therapeutics, Inc. |
Mammalian cell culture-produced neublastin antibodies
|
|
EP2945652B1
(en)
|
2013-01-18 |
2021-07-07 |
Foundation Medicine, Inc. |
Methods of treating cholangiocarcinoma
|
|
CN105164159A
(zh)
|
2013-02-22 |
2015-12-16 |
施特姆森特克斯股份有限公司 |
新的抗体缀合物及其用途
|
|
US20160185853A1
(en)
|
2013-03-14 |
2016-06-30 |
Parkash Gill |
Cancer treatment using antibodies that bind cell surface grp78
|
|
WO2014142882A1
(en)
|
2013-03-14 |
2014-09-18 |
Abbvie Inc. |
Protein purification using displacement chromatography
|
|
KR20150129033A
(ko)
|
2013-03-14 |
2015-11-18 |
애브비 인코포레이티드 |
저 산성 종 조성물 및 이의 제조 및 사용 방법
|
|
BR112015023355A8
(pt)
|
2013-03-14 |
2018-01-30 |
Abbott Lab |
antígenos recombinantes ns3 de hcv e mutantes dos mesmos para detecção de anticorpos aprimorada.
|
|
CA2906417C
(en)
|
2013-03-14 |
2022-06-21 |
Robert Ziemann |
Hcv core lipid binding domain monoclonal antibodies
|
|
EP2968526A4
(en)
|
2013-03-14 |
2016-11-09 |
Abbott Lab |
ANTIGEN-ANTIBODY COMBINATION ASSAY OF HEPATITIS C VIRUS AND METHODS AND COMPOSITIONS FOR USE THEREWITH
|
|
CA2899449A1
(en)
|
2013-03-14 |
2014-10-02 |
Abbvie Inc. |
Low acidic species compositions and methods for producing the same using displacement chromatography
|
|
EP2968508B1
(en)
|
2013-03-15 |
2022-04-27 |
Sanofi Pasteur Biologics, LLC |
Antibodies against clostridium difficile toxins and methods of using the same
|
|
BR112015023797A2
(pt)
|
2013-03-15 |
2017-10-24 |
Abbvie Inc |
proteínas de ligação de especificidade dupla dirigidas contra il-1b e/ou il-17
|
|
US9469686B2
(en)
|
2013-03-15 |
2016-10-18 |
Abbott Laboratories |
Anti-GP73 monoclonal antibodies and methods of obtaining the same
|
|
CA2903546A1
(en)
|
2013-03-15 |
2014-09-25 |
Biogen Ma Inc. |
Treatment and prevention of acute kidney injury using anti-alpha v beta 5 antibodies
|
|
US9499621B2
(en)
|
2013-04-08 |
2016-11-22 |
Cytodyn, Inc. |
Felinized antibodies and methods of treating retroviral infections in felines
|
|
WO2014197369A1
(en)
|
2013-06-06 |
2014-12-11 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for identification, assessment prevention, and treatment of cancer using pd-l1 isoforms
|
|
EP3003372B1
(en)
|
2013-06-07 |
2019-10-09 |
Duke University |
Inhibitors of complement factor h
|
|
AU2014296288B2
(en)
|
2013-07-31 |
2020-02-13 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating thermogenesis using PTH-related and EGF-related molecules
|
|
DK3036320T4
(da)
|
2013-08-19 |
2024-05-06 |
Biogen Ma Inc |
Styring af proteinglycosylering ved hjælp af dyrkningsmedietilsætning og cellekulturprocesparametre
|
|
AU2014312215B2
(en)
|
2013-08-28 |
2020-02-27 |
Abbvie Stemcentrx Llc |
Site-specific antibody conjugation methods and compositions
|
|
EP3038634A4
(en)
|
2013-08-28 |
2017-10-11 |
AbbVie Stemcentrx LLC |
Novel sez6 modulators and methods of use
|
|
EP3049521B1
(en)
|
2013-09-25 |
2019-03-06 |
Cornell University |
Compounds for inducing anti-tumor immunity and methods thereof
|
|
WO2015048330A2
(en)
|
2013-09-25 |
2015-04-02 |
Biogen Idec Ma Inc. |
On-column viral inactivation methods
|
|
US10570204B2
(en)
|
2013-09-26 |
2020-02-25 |
The Medical College Of Wisconsin, Inc. |
Methods for treating hematologic cancers
|
|
WO2015057939A1
(en)
|
2013-10-18 |
2015-04-23 |
Biogen Idec Ma Inc. |
Anti-s1p4 antibodies and uses thereof
|
|
WO2015066190A1
(en)
|
2013-10-29 |
2015-05-07 |
President And Fellows Of Harvard College |
Methods and compositions for inhibting oxidative stress
|
|
US20160272673A1
(en)
|
2013-11-07 |
2016-09-22 |
Abbvie Inc. |
Isolation and purification of dvd-igs
|
|
DK3511422T3
(da)
|
2013-11-12 |
2023-02-06 |
Population Bio Inc |
Fremgangsmåder og sammensætninger til diagnosticering, prognose og behandling af endometriose
|
|
KR102283408B1
(ko)
|
2013-11-15 |
2021-07-29 |
앵스티띠 파스퇴르 |
플라스모듐 팔시파룸 아르테미시닌 내성의 분자 마커
|
|
US20160297875A1
(en)
|
2013-12-07 |
2016-10-13 |
Case Western Reserve University |
Compositions and methods of treating thrombosis
|
|
CA3225453A1
(en)
|
2013-12-19 |
2015-06-25 |
Novartis Ag |
Human mesothelin chimeric antigen receptors and uses thereof
|
|
US11708411B2
(en)
|
2013-12-20 |
2023-07-25 |
Wake Forest University Health Sciences |
Methods and compositions for increasing protective antibody levels induced by pneumococcal polysaccharide vaccines
|
|
US20160289633A1
(en)
|
2013-12-20 |
2016-10-06 |
Biogen Ma Inc. |
Use of Perfusion Seed Cultures to Improve Biopharmaceutical Fed-Batch Production Capacity and Product Quality
|
|
EP2960252A1
(en)
|
2014-06-26 |
2015-12-30 |
Institut Pasteur |
Phospholipase for treatment of immunosuppression
|
|
WO2015108907A2
(en)
|
2014-01-14 |
2015-07-23 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for identification, assessment, prevention, and treatment of melanoma using pd-l1 isoforms
|
|
US10179911B2
(en)
|
2014-01-20 |
2019-01-15 |
President And Fellows Of Harvard College |
Negative selection and stringency modulation in continuous evolution systems
|
|
JOP20200094A1
(ar)
|
2014-01-24 |
2017-06-16 |
Dana Farber Cancer Inst Inc |
جزيئات جسم مضاد لـ pd-1 واستخداماتها
|
|
JOP20200096A1
(ar)
|
2014-01-31 |
2017-06-16 |
Children’S Medical Center Corp |
جزيئات جسم مضاد لـ tim-3 واستخداماتها
|
|
SG11201606624WA
(en)
|
2014-02-11 |
2016-09-29 |
Visterra Inc |
Antibody moleules to dengue virus and uses thereof
|
|
BR112016018891A2
(pt)
|
2014-02-21 |
2017-10-10 |
Abbvie Stemcentrx Llc |
anticorpos anti-dll3 e conjugados de fármacos para uso em melanoma
|
|
US20150259420A1
(en)
|
2014-03-14 |
2015-09-17 |
Novartis Ag |
Antibody molecules to lag-3 and uses thereof
|
|
DK3122869T3
(da)
|
2014-03-24 |
2019-09-09 |
Biogen Ma Inc |
Fremgangsmåder til afhjælpning af glutamindeprivation under pattedyrecellekultur
|
|
IL248511B
(en)
|
2014-05-13 |
2022-07-01 |
Bavarian Nordic As |
Combination therapy for treating cancer with a poxvirus expressing a tumor antigen and a monoclonal antibody against tim-3
|
|
SG10201703965SA
(en)
|
2014-06-03 |
2017-06-29 |
Xbiotech Inc |
Compositions and methods for treating and preventing staphylococcus aureus infections
|
|
TWI719942B
(zh)
|
2014-07-21 |
2021-03-01 |
瑞士商諾華公司 |
使用ｃｄ３３嵌合抗原受體治療癌症
|
|
WO2016012623A1
(en)
|
2014-07-25 |
2016-01-28 |
Theravectys |
Lentiviral vectors for regulated expression of a chimeric antigen receptor molecule
|
|
US10851149B2
(en)
|
2014-08-14 |
2020-12-01 |
The Trustees Of The University Of Pennsylvania |
Treatment of cancer using GFR α-4 chimeric antigen receptor
|
|
JP6675383B2
(ja)
|
2014-08-19 |
2020-04-01 |
イムーンダイアグノスティック・アー・ゲー |
慢性腎疾患の治療のための医薬および装置
|
|
PL3183268T3
(pl)
|
2014-08-19 |
2020-09-07 |
Novartis Ag |
Chimeryczny receptor antygenowy (CAR) anty-CD123 do zastosowania w leczeniu nowotworu złośliwego
|
|
US10724096B2
(en)
|
2014-09-05 |
2020-07-28 |
Population Bio, Inc. |
Methods and compositions for inhibiting and treating neurological conditions
|
|
KR20170060042A
(ko)
|
2014-09-13 |
2017-05-31 |
노파르티스 아게 |
Alk 억제제의 조합 요법
|
|
IL250902B
(en)
|
2014-09-16 |
2022-08-01 |
Symphogen As |
Anti-met antibodies and compositions
|
|
SI3200822T1
(sl)
|
2014-09-30 |
2021-10-29 |
Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts |
Vezavne molekule, posebno antiteles, vezanih na L1CAM (CD171)
|
|
US20170209574A1
(en)
|
2014-10-03 |
2017-07-27 |
Novartis Ag |
Combination therapies
|
|
MA40035A
(fr)
|
2014-10-14 |
2016-04-21 |
Dana Farber Cancer Inst Inc |
Molécules d'anticorps de pd-l1 et leurs utilisations
|
|
US11124822B2
(en)
|
2014-10-17 |
2021-09-21 |
Carnegie Mellon University |
Enhanced biomolecule detection assays based on tyramide signal amplification and gammaPNA probes
|
|
MA41685A
(fr)
|
2014-10-17 |
2017-08-22 |
Biogen Ma Inc |
Supplémentation en cuivre pour la régulation de la glycosylation dans un procédé de culture cellulaire de mammifère
|
|
WO2016077052A2
(en)
|
2014-10-22 |
2016-05-19 |
President And Fellows Of Harvard College |
Evolution of proteases
|
|
MA40864A
(fr)
|
2014-10-31 |
2017-09-05 |
Biogen Ma Inc |
Hypotaurine, gaba, bêta-alanine et choline pour la régulation de l'accumulation de sous-produits résiduaires dans des procédés de culture de cellules mammifères
|
|
SI3215527T1
(sl)
|
2014-11-05 |
2025-04-30 |
Annexon, Inc. |
Humanizirana protitelesa proti komplementnemu faktorju C1q in njihova uporaba
|
|
SI3215530T1
(sl)
|
2014-11-07 |
2020-02-28 |
Sesen Bio, Inc. |
Izboljšana protitelesa IL-6
|
|
WO2016073894A1
(en)
|
2014-11-07 |
2016-05-12 |
Eleven Biotherapeutics, Inc. |
Therapeutic agents with increased ocular retention
|
|
CN107429075B
(zh)
|
2014-11-17 |
2022-11-01 |
卡内基梅隆大学 |
可激活的双组份光敏剂
|
|
US11033637B2
(en)
|
2014-11-21 |
2021-06-15 |
University Of Maryland, Baltimore |
Targeted structure-specific particulate delivery systems
|
|
ES3015000T3
(en)
|
2014-12-08 |
2025-04-28 |
Dana Farber Cancer Inst Inc |
Methods for upregulating immune responses using combinations of anti-rgmb and anti-pd-1 agents
|
|
WO2016094881A2
(en)
|
2014-12-11 |
2016-06-16 |
Abbvie Inc. |
Lrp-8 binding proteins
|
|
EP3034620A1
(en)
|
2014-12-17 |
2016-06-22 |
Diaxonhit |
Compositions and methods for diagnosing thyroid cancer
|
|
EP3233918A1
(en)
|
2014-12-19 |
2017-10-25 |
Novartis AG |
Combination therapies
|
|
FR3030758A1
(fr)
|
2014-12-19 |
2016-06-24 |
Inst Nat De La Rech Agronomique (Inra) |
Marqueurs diagnostiques de la maladie de crohn
|
|
EP3242893A1
(en)
|
2015-01-08 |
2017-11-15 |
Biogen MA Inc. |
Lingo-1 antagonists and uses for treatment of demyelinating disorders
|
|
EP3265491A1
(en)
|
2015-03-03 |
2018-01-10 |
Xoma (Us) Llc |
Treatment of post-prandial hyperinsulinemia and hypoglycemia after bariatric surgery
|
|
US20180042998A1
(en)
|
2015-03-10 |
2018-02-15 |
University Of Massachusetts |
Targeting gdf6 and bmp signaling for anti-melanoma therapy
|
|
CN116327915A
(zh)
|
2015-04-03 |
2023-06-27 |
佐马技术有限公司 |
使用TGF-β抑制剂和PD-1抑制剂治疗癌症
|
|
WO2016168631A1
(en)
|
2015-04-17 |
2016-10-20 |
President And Fellows Of Harvard College |
Vector-based mutagenesis system
|
|
EP3285811A1
(en)
|
2015-04-21 |
2018-02-28 |
Institut Gustave Roussy |
Therapeutic methods, products and compositions inhibiting znf555
|
|
EP3095465A1
(en)
|
2015-05-19 |
2016-11-23 |
U3 Pharma GmbH |
Combination of fgfr4-inhibitor and bile acid sequestrant
|
|
FR3036287A1
(fr)
|
2015-05-19 |
2016-11-25 |
Univ Bordeaux |
Traitement et detection des trypanosomes
|
|
HRP20200262T1
(hr)
|
2015-05-29 |
2020-05-29 |
Abbvie Inc. |
Protutijela protiv cd40 i njihova upotreba
|
|
TW201710286A
(zh)
|
2015-06-15 |
2017-03-16 |
艾伯維有限公司 |
抗ｖｅｇｆ、ｐｄｇｆ及／或其受體之結合蛋白
|
|
US10392674B2
(en)
|
2015-07-22 |
2019-08-27 |
President And Fellows Of Harvard College |
Evolution of site-specific recombinases
|
|
WO2017015559A2
(en)
|
2015-07-23 |
2017-01-26 |
President And Fellows Of Harvard College |
Evolution of bt toxins
|
|
PL3317301T3
(pl)
|
2015-07-29 |
2021-11-15 |
Novartis Ag |
Terapie skojarzone zawierające cząsteczki przeciwciał przeciw lag-3
|
|
WO2017019897A1
(en)
|
2015-07-29 |
2017-02-02 |
Novartis Ag |
Combination therapies comprising antibody molecules to tim-3
|
|
WO2017019896A1
(en)
|
2015-07-29 |
2017-02-02 |
Novartis Ag |
Combination therapies comprising antibody molecules to pd-1
|
|
WO2017019895A1
(en)
|
2015-07-30 |
2017-02-02 |
President And Fellows Of Harvard College |
Evolution of talens
|
|
CA2994841A1
(en)
|
2015-08-06 |
2017-02-09 |
Xoma (Us) Llc |
Antibody fragments against the insulin receptor and uses thereof to treat hypoglycemia
|
|
EP3932953A1
(en)
|
2015-08-28 |
2022-01-05 |
F. Hoffmann-La Roche AG |
Anti-hypusine antibodies and uses thereof
|
|
EP3350220B1
(en)
|
2015-09-15 |
2021-05-19 |
Scholar Rock, Inc. |
Anti-pro/latent-myostatin antibodies and uses thereof
|
|
US11207393B2
(en)
|
2015-10-16 |
2021-12-28 |
President And Fellows Of Harvard College |
Regulatory T cell PD-1 modulation for regulating T cell effector immune responses
|
|
SG10202104041PA
(en)
|
2015-10-23 |
2021-06-29 |
Harvard College |
Nucleobase editors and uses thereof
|
|
WO2017075329A2
(en)
|
2015-10-29 |
2017-05-04 |
Dana-Farber Cancer Institute, Inc. |
Methods for identification, assessment, prevention, and treatment of metabolic disorders using pm20d1 and n-lipidated amino acids
|
|
CN108473559A
(zh)
|
2015-11-10 |
2018-08-31 |
威特拉公司 |
特异性结合脂多糖的抗体分子-药物共轭物及其应用
|
|
JP2019506363A
(ja)
|
2015-11-25 |
2019-03-07 |
ビステラ， インコーポレイテッド |
Ａｐｒｉｌに対する抗体分子およびその使用
|
|
JP6975720B2
(ja)
|
2015-11-30 |
2021-12-01 |
シェ、ヤンホイXie Yanhui |
腫瘍の診断および治療におけるＡｋｔ２の使用
|
|
BR112018012138A2
(pt)
|
2015-12-17 |
2018-12-04 |
Novartis Ag |
moléculas de anticorpo para pd-1 e usos das mesmas
|
|
JP2019502695A
(ja)
|
2015-12-17 |
2019-01-31 |
ノバルティス アーゲー |
ＰＤ−１に対する抗体分子とＣ−Ｍｅｔ阻害剤との組合せおよびその使用
|
|
US10287345B2
(en)
|
2016-01-08 |
2019-05-14 |
Scholar Rock, Inc. |
Methods for inhibiting myostatin activation by administering anti-pro/latent myostatin antibodies
|
|
BR112018017031A2
(pt)
|
2016-02-23 |
2019-01-22 |
Sesen Bio Inc |
formulações de antagonista de il-6 e usos das mesmas
|
|
JP2019509282A
(ja)
|
2016-02-29 |
2019-04-04 |
ファウンデーション・メディシン・インコーポレイテッド |
癌の治療方法
|
|
KR20180119632A
(ko)
|
2016-02-29 |
2018-11-02 |
제넨테크, 인크. |
암에 대한 치료 및 진단 방법
|
|
KR20230088508A
(ko)
|
2016-03-11 |
2023-06-19 |
스칼러 락, 인크. |
TGFβ1-결합 이뮤노글로불린 및 그의 용도
|
|
WO2017160599A1
(en)
|
2016-03-14 |
2017-09-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Use of cd300b antagonists to treat sepsis and septic shock
|
|
US11186641B2
(en)
|
2016-03-17 |
2021-11-30 |
Oslo Universitetssykehus Hf |
Fusion proteins targeting tumour associated macrophages for treating cancer
|
|
AU2017238172B2
(en)
|
2016-03-21 |
2024-06-27 |
Marengo Therapeutics, Inc. |
Multispecific and multifunctional molecules and uses thereof
|
|
CA3018216A1
(en)
|
2016-03-25 |
2017-09-28 |
Visterra, Inc. |
Formulations of antibody molecules to dengue virus
|
|
EP3439692A4
(en)
|
2016-04-08 |
2020-01-22 |
ITI Health, Inc. |
ANTIBODIES BINDING PLECTIN-1 AND USES THEREOF
|
|
WO2017181098A2
(en)
|
2016-04-15 |
2017-10-19 |
Visterra, Inc. |
Antibody molecules to zika virus and uses thereof
|
|
CN110291402B
(zh)
|
2016-06-27 |
2023-09-01 |
朱诺治疗学股份有限公司 |
鉴定肽表位的方法、结合此类表位的分子和相关用途
|
|
MA45491A
(fr)
|
2016-06-27 |
2019-05-01 |
Juno Therapeutics Inc |
Épitopes à restriction cmh-e, molécules de liaison et procédés et utilisations associés
|
|
MA45668A
(fr)
|
2016-07-13 |
2019-05-22 |
Biogen Ma Inc |
Schémas posologiques d'antagonistes de lingo-1 et leurs utilisations pour le traitement de troubles de démyélinisation
|
|
CA3030837A1
(en)
|
2016-07-15 |
2018-01-18 |
Novartis Ag |
Treatment and prevention of cytokine release syndrome using a chimeric antigen receptor in combination with a kinase inhibitor
|
|
WO2018022479A1
(en)
|
2016-07-25 |
2018-02-01 |
Biogen Ma Inc. |
Anti-hspa5 (grp78) antibodies and uses thereof
|
|
WO2018026748A1
(en)
|
2016-08-01 |
2018-02-08 |
Xoma (Us) Llc |
Parathyroid hormone receptor 1 (pth1r) antibodies and uses thereof
|
|
WO2018052556A1
(en)
|
2016-08-02 |
2018-03-22 |
Visterra, Inc. |
Engineered polypeptides and uses thereof
|
|
AU2017331277B2
(en)
|
2016-09-23 |
2024-05-30 |
Marengo Therapeutics, Inc. |
Multispecific antibody molecules comprising lambda and kappa light chains
|
|
JP2019534710A
(ja)
|
2016-09-28 |
2019-12-05 |
ゾーマ （ユーエス） リミテッド ライアビリティ カンパニー |
インターロイキン２に結合する抗体およびその使用
|
|
EP4521116A3
(en)
|
2016-10-03 |
2025-05-28 |
Abbott Laboratories |
Improved methods of assessing uch-l1 status in patient samples
|
|
KR20240153612A
(ko)
|
2016-10-07 |
2024-10-23 |
노파르티스 아게 |
암의 치료를 위한 키메라 항원 수용체
|
|
WO2018071576A1
(en)
|
2016-10-14 |
2018-04-19 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Treatment of tumors by inhibition of cd300f
|
|
IL267565B2
(en)
|
2016-12-23 |
2025-02-01 |
Visterra Inc |
Methods of producing binding polypeptides containing covalently linked heavy chains and light chains
|
|
PT3565592T
(pt)
|
2017-01-06 |
2023-05-31 |
Scholar Rock Inc |
Tratamento de doenças metabólicas através da inibição da ativação da miostatina
|
|
BR112019013908A2
(pt)
|
2017-01-06 |
2020-02-04 |
Scholar Rock Inc |
inibidores de tgfss1 isoforma-específicos, contexto-permissivos, e seus usos
|
|
DK3565592T5
(da)
|
2017-01-06 |
2024-09-02 |
Scholar Rock Inc |
Behandling af stofskiftesygdomme ved inhibering af myostatinaktivering
|
|
CN110312530A
(zh)
|
2017-01-13 |
2019-10-08 |
中央研究院 |
用以治疗心肌梗塞的可重复装载的水胶系统
|
|
WO2018130661A1
(en)
|
2017-01-13 |
2018-07-19 |
Academia Sinica |
Reloadable hydrogel system for treating brain conditions
|
|
ES2994374T3
(en)
|
2017-01-18 |
2025-01-23 |
Visterra Inc |
Antibody molecule-drug conjugates and uses thereof
|
|
US10240205B2
(en)
|
2017-02-03 |
2019-03-26 |
Population Bio, Inc. |
Methods for assessing risk of developing a viral disease using a genetic test
|
|
US11623945B2
(en)
|
2017-02-06 |
2023-04-11 |
The United States Of America, As Represented By The Secretary Of Agriculture |
Immunostimulating compositions and uses therefore
|
|
WO2018151820A1
(en)
|
2017-02-16 |
2018-08-23 |
Elstar Therapeutics, Inc. |
Multifunctional molecules comprising a trimeric ligand and uses thereof
|
|
CN110382529B
(zh)
|
2017-03-02 |
2024-03-08 |
诺华股份有限公司 |
工程化的异源二聚体蛋白质
|
|
JP7346300B2
(ja)
|
2017-03-23 |
2023-09-19 |
アボット・ラボラトリーズ |
早期バイオマーカーであるユビキチンカルボキシ末端ヒドロラーゼｌ１を使用する、ヒト対象における外傷性脳損傷の程度の診断及び決定の一助となるための方法
|
|
EP3599843A4
(en)
|
2017-03-24 |
2021-01-13 |
The Regents of the University of California |
PROTEOGLYCAN IRREGULARITIES IN ABNORMAL FIBROBLASTS AND THERAPIES BASED ON THEM
|
|
AU2018249493A1
(en)
|
2017-04-03 |
2019-09-19 |
Oncxerna Therapeutics, Inc. |
Methods for treating cancer using PS-targeting antibodies with immuno-oncology agents
|
|
EP3609915A1
(en)
|
2017-04-12 |
2020-02-19 |
Pfizer Inc |
Antibodies having conditional affinity and methods of use thereof
|
|
CN110546513A
(zh)
|
2017-04-15 |
2019-12-06 |
雅培实验室 |
使用早期生物标记物帮助超急性诊断和确定人类受试者中的创伤性脑损伤的方法
|
|
WO2018195283A1
(en)
|
2017-04-19 |
2018-10-25 |
Elstar Therapeutics, Inc. |
Multispecific molecules and uses thereof
|
|
EP3615566B1
(en)
|
2017-04-28 |
2023-12-20 |
Marengo Therapeutics, Inc. |
Multispecific molecules comprising a non-immunoglobulin heterodimerization domain and uses thereof
|
|
BR112019022476A2
(pt)
|
2017-04-28 |
2020-05-12 |
Abbott Laboratories |
Métodos para o auxílio no diagnóstico e determinação hiperagudos de lesão cerebral traumática usando biomarcadores iniciais em pelo menos duas amostras a partir do mesmo ser humano
|
|
US10865238B1
(en)
|
2017-05-05 |
2020-12-15 |
Duke University |
Complement factor H antibodies
|
|
CN110753703B
(zh)
|
2017-05-23 |
2024-04-09 |
德国亥姆霍兹慕尼黑中心健康与环境研究中心（有限公司） |
新的cd73抗体、其制备和用途
|
|
US10866251B2
(en)
|
2017-05-25 |
2020-12-15 |
Abbott Laboratories |
Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers
|
|
BR112019025313A2
(pt)
|
2017-05-30 |
2020-06-23 |
Abbott Laboratories |
Métodos para auxílio no diagnóstico e avaliação de uma lesão cerebral traumática leve em um indivíduo humano usando troponina cardíaca i
|
|
JP2020522254A
(ja)
|
2017-05-31 |
2020-07-30 |
エルスター セラピューティクス， インコーポレイテッド |
骨髄増殖性白血病（ｍｐｌ）タンパク質に結合する多特異性分子およびその使用
|
|
BR112019024291A2
(pt)
|
2017-06-09 |
2020-07-28 |
Providence Health & Services-Oregon |
utilização de cd39 e de cd103 para a identificação de células t tumorais humanas reativas para o tratamento do câncer
|
|
EP3642240A1
(en)
|
2017-06-22 |
2020-04-29 |
Novartis AG |
Antibody molecules to cd73 and uses thereof
|
|
WO2019005817A2
(en)
|
2017-06-26 |
2019-01-03 |
Bio-Techne Corporation |
HYBRIDOMIC CLONES, MONOCLONAL ANTIBODIES DIRECTED AGAINST VSIG-4, AND METHODS OF MAKING AND USING SAME
|
|
CN111050791A
(zh)
|
2017-06-27 |
2020-04-21 |
诺华股份有限公司 |
用于抗tim-3抗体的给药方案及其用途
|
|
CA3068041C
(en)
|
2017-07-03 |
2024-06-25 |
Abbott Laboratories |
Improved methods for measuring ubiquitin carboxy-terminal hydrolase l1 levels in blood
|
|
US11447809B2
(en)
|
2017-07-06 |
2022-09-20 |
President And Fellows Of Harvard College |
Evolution of tRNA synthetases
|
|
BR112020000698A2
(pt)
|
2017-07-14 |
2020-07-14 |
Pfizer Inc. |
anticorpos contra madcam
|
|
EP3431496A1
(en)
|
2017-07-19 |
2019-01-23 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Anti- isoasp7 amyloid beta antibodies and uses thereof
|
|
CA3070095A1
(en)
|
2017-07-20 |
2019-01-24 |
Novartis Ag |
Dosage regimens of anti-lag-3 antibodies and uses thereof
|
|
EP3658583A1
(en)
|
2017-07-28 |
2020-06-03 |
Scholar Rock, Inc. |
Ltbp complex-specific inhibitors of tgf-beta 1 and uses thereof
|
|
WO2019035938A1
(en)
|
2017-08-16 |
2019-02-21 |
Elstar Therapeutics, Inc. |
MULTISPECIFIC MOLECULES BINDING TO BCMA AND USES THEREOF
|
|
EP3444275A1
(en)
|
2017-08-16 |
2019-02-20 |
Exiris S.r.l. |
Monoclonal antibody anti-fgfr4
|
|
JP2020534025A
(ja)
|
2017-08-25 |
2020-11-26 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
ＢｏＮＴペプチダーゼの進化
|
|
US11624130B2
(en)
|
2017-09-18 |
2023-04-11 |
President And Fellows Of Harvard College |
Continuous evolution for stabilized proteins
|
|
ES2759622T3
(es)
|
2017-10-02 |
2020-05-11 |
Certest Biotec S L |
Anticuerpos anti-Dps y dispositivos de prueba para la detección de bacterias del género Campylobacter
|
|
CN119192374A
(zh)
|
2017-10-02 |
2024-12-27 |
威特拉公司 |
Cd138抗体分子及其用途
|
|
CN112020648A
(zh)
|
2017-10-04 |
2020-12-01 |
赫斯佩瑞克斯股份公司 |
针对癌症个体化疗法的制品和方法
|
|
EP3697816A1
(en)
|
2017-10-19 |
2020-08-26 |
Debiopharm International S.A. |
Combination product for the treatment of cancer
|
|
WO2019077165A1
(en)
|
2017-10-20 |
2019-04-25 |
Institut Curie |
DAP10 / 12-BASED CHIMERIC ANTIGENIC RECEPTORS (CAR) ADAPTED FOR RUSH
|
|
CA3081602A1
(en)
|
2017-11-16 |
2019-05-23 |
Novartis Ag |
Combination therapies
|
|
US20200377571A1
(en)
|
2017-12-08 |
2020-12-03 |
Elstar Therapeutics, Inc. |
Multispecific molecules and uses thereof
|
|
WO2019113525A2
(en)
|
2017-12-09 |
2019-06-13 |
Abbott Laboratories |
Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (tbi), using glial fibrillary acidic protein (gfap) and/or ubiquitin carboxy-terminal hydrolase l1 (uch-l1)
|
|
EP3721234A1
(en)
|
2017-12-09 |
2020-10-14 |
Abbott Laboratories |
Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of gfap and uch-l1
|
|
WO2019139987A1
(en)
|
2018-01-09 |
2019-07-18 |
Elstar Therapeutics, Inc. |
Calreticulin binding constructs and engineered t cells for the treatment of diseases
|
|
EP3746477A1
(en)
|
2018-02-02 |
2020-12-09 |
Bio-Techne Corporation |
Compounds that modulate the interaction of vista and vsig3 and methods of making and using
|
|
WO2019168897A2
(en)
|
2018-02-28 |
2019-09-06 |
Dana-Farber Cancer Institute, Inc. |
Methods for treating cancer using combinations of anti-btnl2 and immune checkpoint blockade agents
|
|
CA3093772C
(en)
|
2018-03-12 |
2024-04-16 |
Zoetis Services Llc |
Anti-ngf antibodies and methods thereof
|
|
US20210009711A1
(en)
|
2018-03-14 |
2021-01-14 |
Elstar Therapeutics, Inc. |
Multifunctional molecules and uses thereof
|
|
EP3765517A1
(en)
|
2018-03-14 |
2021-01-20 |
Elstar Therapeutics, Inc. |
Multifunctional molecules that bind to calreticulin and uses thereof
|
|
WO2019180272A1
(en)
|
2018-03-23 |
2019-09-26 |
Fundación Instituto De Investigación Sanitaria De Santiago De Compostela |
Anti-leptin affinity reagents for use in the treatment of obesity and other leptin-resistance associated diseases
|
|
HRP20230744T1
(hr)
|
2018-03-26 |
2023-10-27 |
Glycanostics S.R.O. |
Sredstva i metode glikoprofiliranja proteina
|
|
US20210147547A1
(en)
|
2018-04-13 |
2021-05-20 |
Novartis Ag |
Dosage Regimens For Anti-Pd-L1 Antibodies And Uses Thereof
|
|
TWI869346B
(zh)
|
2018-05-30 |
2025-01-11 |
瑞士商諾華公司 |
Ｅｎｔｐｄ２抗體、組合療法、及使用該等抗體和組合療法之方法
|
|
WO2019241649A1
(en)
|
2018-06-14 |
2019-12-19 |
President And Fellows Of Harvard College |
Evolution of cytidine deaminases
|
|
EP3810269A2
(en)
|
2018-06-19 |
2021-04-28 |
Atarga, LLC |
Antibody molecules to complement component 5 and uses thereof
|
|
AU2019297451A1
(en)
|
2018-07-03 |
2021-01-28 |
Marengo Therapeutics, Inc. |
Anti-TCR antibody molecules and uses thereof
|
|
WO2020008083A1
(es)
|
2018-07-05 |
2020-01-09 |
Consejo Superior De Investigaciones Científicas |
Diana terapéutica en receptores de quimiocinas para la selección de compuestos útiles para el tratamiento de procesos patológicos que implican la señalización de quimiocinas
|
|
TW202019957A
(zh)
|
2018-07-11 |
2020-06-01 |
美商供石公司 |
TGFβ1抑制劑及其用途
|
|
EP4019046A1
(en)
|
2018-07-11 |
2022-06-29 |
Scholar Rock, Inc. |
Isoform selective tgfbeta1 inhibitors and use thereof
|
|
MX2021000347A
(es)
|
2018-07-11 |
2021-04-19 |
Scholar Rock Inc |
Inhibidores de tgf?1 selectivos de isoforma, de alta afinidad y usos de los mismos.
|
|
WO2020021465A1
(en)
|
2018-07-25 |
2020-01-30 |
Advanced Accelerator Applications (Italy) S.R.L. |
Method of treatment of neuroendocrine tumors
|
|
HRP20221504T1
(hr)
|
2018-08-08 |
2023-03-31 |
Pml Screening, Llc |
Postupci procjene rizika od razvoja progresivne multifokalne leukoencefalopatije uzrokovane john cunningham virusom pomoću genetskog testiranja
|
|
AU2019346645A1
(en)
|
2018-09-27 |
2021-04-29 |
Marengo Therapeutics, Inc. |
CSF1R/CCR2 multispecific antibodies
|
|
IL281988B2
(en)
|
2018-10-05 |
2025-03-01 |
Bavarian Nordic As |
Combination therapy for treating cancer with an intravenous administration of a recombinant mva and an immune checkpoint antagonist or agonist
|
|
UY38407A
(es)
|
2018-10-15 |
2020-05-29 |
Novartis Ag |
Anticuerpos estabilizadores de trem2
|
|
BR112021007765A2
(pt)
|
2018-10-23 |
2021-08-03 |
Scholar Rock, Inc. |
inibidores seletivos de rgmc e uso dos mesmos
|
|
WO2020086408A1
(en)
|
2018-10-26 |
2020-04-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
A high-yield perfusion-based transient gene expression bioprocess
|
|
MX2021005560A
(es)
|
2018-11-20 |
2021-06-23 |
Bavarian Nordic As |
Terapia para el tratamiento del cancer con administracion intratumoral y/o intravenosa de un virus vaccinia ankara (mva) recombinante que codifica ligando 4-1bbl (cd137l) y/o ligando del cumulo o grupo de diferenciacion 40 (cd40l).
|
|
US20220281970A1
(en)
|
2018-12-20 |
2022-09-08 |
Novartis Ag |
Pharmaceutical Combinations
|
|
US12084500B2
(en)
|
2019-01-23 |
2024-09-10 |
New York University |
Antibodies specific to delta 1 chain of T cell receptor
|
|
AR117918A1
(es)
|
2019-01-30 |
2021-09-01 |
Scholar Rock Inc |
COMPLEJOS-ESPECÍFICOS LTBP INHIBIDORES DE TGFb Y SUS USOS
|
|
US11738050B2
(en)
|
2019-02-01 |
2023-08-29 |
Regents Of The University Of Minnesota |
Compounds binding to fibroblast activation protein alpha
|
|
EP3693063A1
(en)
|
2019-02-06 |
2020-08-12 |
Diaccurate |
Methods and compositions for treating cancer
|
|
EP3696191A1
(en)
|
2019-02-14 |
2020-08-19 |
Fundación Instituto de Investigación contra la Leucemia Josep Carreras (IJC) |
Car t-cells for the treatment of cd1a-positive cancer
|
|
US10871640B2
(en)
|
2019-02-15 |
2020-12-22 |
Perkinelmer Cellular Technologies Germany Gmbh |
Methods and systems for automated imaging of three-dimensional objects
|
|
CA3130754A1
(en)
|
2019-02-21 |
2020-08-27 |
Marengo Therapeutics, Inc. |
Multifunctional molecules that bind to t cell related cancer cells and uses thereof
|
|
SG11202108955QA
(en)
|
2019-02-21 |
2021-09-29 |
Marengo Therapeutics Inc |
Antibody molecules that bind to nkp30 and uses thereof
|
|
EP3927745A1
(en)
|
2019-02-21 |
2021-12-29 |
Marengo Therapeutics, Inc. |
Multifunctional molecules that bind to t cells and uses thereof to treat autoimmune disorders
|
|
CN114127113A
(zh)
|
2019-02-21 |
2022-03-01 |
马伦戈治疗公司 |
与钙网蛋白结合的多功能分子及其用途
|
|
CN114126714A
(zh)
|
2019-02-21 |
2022-03-01 |
马伦戈治疗公司 |
抗tcr抗体分子及其用途
|
|
SG11202110732XA
(en)
|
2019-03-29 |
2021-10-28 |
Atarga Llc |
Anti fgf23 antibody
|
|
EP3962529A4
(en)
|
2019-04-30 |
2023-11-01 |
Dana-Farber Cancer Institute, Inc. |
Methods for treating cancer using combinations of anti-cx3cr1 and immune checkpoint blockade agents
|
|
WO2020257289A2
(en)
|
2019-06-17 |
2020-12-24 |
Visterra, Inc. |
Humanized antibody molecules to cd138 and uses thereof
|
|
EP4004025A1
(en)
|
2019-07-26 |
2022-06-01 |
Visterra, Inc. |
Interleukin-2 agents and uses thereof
|
|
PL4007777T3
(pl)
|
2019-08-02 |
2024-03-11 |
Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS) |
(CAR)T-komórki przeciw BCMA do leczenia szpiczaka mnogiego
|
|
WO2021023860A1
(en)
|
2019-08-07 |
2021-02-11 |
Db Biotech, As |
Improved horseradish peroxidase polypeptides
|
|
WO2021044009A1
(en)
|
2019-09-04 |
2021-03-11 |
Deutsches Zentrum Für Neurodegenerative Erkrankungen E.V. (Dzne) |
Herv inhibitors for use in treating tauopathies
|
|
TW202124446A
(zh)
|
2019-09-18 |
2021-07-01 |
瑞士商諾華公司 |
與ｅｎｔｐｄ２抗體之組合療法
|
|
US20220348651A1
(en)
|
2019-09-18 |
2022-11-03 |
Novartis Ag |
Entpd2 antibodies, combination therapies, and methods of using the antibodies and combination therapies
|
|
KR20220103947A
(ko)
|
2019-10-21 |
2022-07-25 |
노파르티스 아게 |
베네토클락스 및 tim-3 억제제를 사용한 조합 요법
|
|
MX2022004769A
(es)
|
2019-10-21 |
2022-05-16 |
Novartis Ag |
Inhibidores de tim-3 y sus usos.
|
|
IL293009A
(en)
|
2019-11-20 |
2022-07-01 |
Bavarian Nordic As |
Recombinant mva viruses for intratumoral and/or intravenous administration for treating cancer
|
|
EP4077389A1
(en)
|
2019-12-20 |
2022-10-26 |
Novartis AG |
Combination of anti tim-3 antibody mbg453 and anti tgf-beta antibody nis793, with or without decitabine or the anti pd-1 antibody spartalizumab, for treating myelofibrosis and myelodysplastic syndrome
|
|
WO2021138407A2
(en)
|
2020-01-03 |
2021-07-08 |
Marengo Therapeutics, Inc. |
Multifunctional molecules that bind to cd33 and uses thereof
|
|
JP2023510793A
(ja)
|
2020-01-11 |
2023-03-15 |
スカラー ロック インコーポレイテッド |
ＴＧＦβ阻害剤およびその使用
|
|
WO2021142448A2
(en)
|
2020-01-11 |
2021-07-15 |
Scholar Rock,Inc. |
Tgf-beta inhibitors and use thereof
|
|
TWI869528B
(zh)
|
2020-01-13 |
2025-01-11 |
美商威特拉公司 |
C5ar1抗體分子及其用途
|
|
US20230058489A1
(en)
|
2020-01-17 |
2023-02-23 |
Novartis Ag |
Combination comprising a tim-3 inhibitor and a hypomethylating agent for use in treating myelodysplastic syndrome or chronic myelomonocytic leukemia
|
|
US20230075965A1
(en)
|
2020-01-24 |
2023-03-09 |
Constantine S. Mitsiades |
Uses of biomarkers for improving immunotherapy
|
|
CA3167027A1
(en)
|
2020-02-05 |
2021-08-12 |
Larimar Therapeutics, Inc. |
Tat peptide binding proteins and uses thereof
|
|
US20230139885A1
(en)
|
2020-03-11 |
2023-05-04 |
Fundació Institut De Recerca Contra La Leucèmia Josep Carreras |
Cd22 targeting-moiety for the treatment of b-cell acute lymphoblastic leukemia (b-all)
|
|
US11969476B2
(en)
|
2020-04-03 |
2024-04-30 |
Visterra, Inc. |
Antibody molecule-drug conjugates and uses thereof
|
|
GB2612450A
(en)
|
2020-04-24 |
2023-05-03 |
Marengo Therapeutics Inc |
Multifunctional molecules that bind to T cell related cancer cells and uses thereof
|
|
CN115461363A
(zh)
|
2020-05-01 |
2022-12-09 |
诺华股份有限公司 |
免疫球蛋白变体
|
|
WO2021220215A1
(en)
|
2020-05-01 |
2021-11-04 |
Novartis Ag |
Engineered immunoglobulins
|
|
EP4149548A4
(en)
|
2020-05-13 |
2024-05-08 |
Disc Medicine, Inc. |
ANTI-HEMOJUVELIN ANTIBODIES (HJV) FOR THE TREATMENT OF MYELOFIBROSIS
|
|
WO2021239666A1
(en)
|
2020-05-26 |
2021-12-02 |
Diaccurate |
Therapeutic methods
|
|
US20230235080A1
(en)
|
2020-06-03 |
2023-07-27 |
Bionecure Therapeutics, Inc. |
Trophoblast cell-surface antigen-2 (trop-2) antibodies
|
|
TW202216195A
(zh)
|
2020-06-24 |
2022-05-01 |
美商威特拉公司 |
April抗體分子及其用途
|
|
CN116390772A
(zh)
|
2020-07-07 |
2023-07-04 |
博泰康医药公司 |
新型美登素类似物作为adc有效载荷及其在癌症治疗中的用途
|
|
WO2022026592A2
(en)
|
2020-07-28 |
2022-02-03 |
Celltas Bio, Inc. |
Antibody molecules to coronavirus and uses thereof
|
|
KR20230042301A
(ko)
|
2020-08-04 |
2023-03-28 |
애벗트 라보라토리이즈 |
샘플에서 sars-cov-2 단백질을 검출하기 위한 개선된 방법 및 키트
|
|
GB2616354A
(en)
|
2020-08-26 |
2023-09-06 |
Marengo Therapeutics Inc |
Methods of detecting TRBC1 or TRBC2
|
|
CN116917316A
(zh)
|
2020-08-26 |
2023-10-20 |
马伦戈治疗公司 |
与NKp30结合的抗体分子及其用途
|
|
CA3190755A1
(en)
|
2020-08-26 |
2022-03-03 |
Andreas Loew |
Multifunctional molecules that bind to calreticulin and uses thereof
|
|
EP4204020A1
(en)
|
2020-08-31 |
2023-07-05 |
Advanced Accelerator Applications International S.A. |
Method of treating psma-expressing cancers
|
|
EP4204021A1
(en)
|
2020-08-31 |
2023-07-05 |
Advanced Accelerator Applications International S.A. |
Method of treating psma-expressing cancers
|
|
EP4228764A1
(en)
|
2020-10-14 |
2023-08-23 |
Five Prime Therapeutics, Inc. |
Anti-c-c chemokine receptor 8 (ccr8) antibodies and methods of use thereof
|
|
EP4251647A1
(en)
|
2020-11-24 |
2023-10-04 |
Bio-Techne Corporation |
Anti-severe acute respiratory syndrome coronavirus antibodies
|
|
WO2023102384A1
(en)
|
2021-11-30 |
2023-06-08 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
|
CA3198161A1
(en)
|
2020-12-01 |
2022-06-09 |
Beth MCQUISTON |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
|
MX2023006599A
(es)
|
2020-12-04 |
2023-06-19 |
Visterra Inc |
Metodos de uso de agentes de interleucina-2.
|
|
CA3202339A1
(en)
|
2020-12-18 |
2022-06-23 |
Mei Jang |
Protein compositions and methods for producing and using the same
|
|
EP4271998A1
(en)
|
2020-12-30 |
2023-11-08 |
Abbott Laboratories |
Methods for determining sars-cov-2 antigen and anti-sars-cov-2 antibody in a sample
|
|
WO2022153212A1
(en)
|
2021-01-13 |
2022-07-21 |
Axon Neuroscience Se |
Antibodies neutralizing sars-cov-2
|
|
MX2023008598A
(es)
|
2021-01-20 |
2023-08-10 |
Visterra Inc |
Agentes de interleuquina-2 y usos de los mismos.
|
|
US20240141060A1
(en)
|
2021-01-29 |
2024-05-02 |
Novartis Ag |
Dosage regimes for anti-cd73 and anti-entpd2 antibodies and uses thereof
|
|
US20240230671A9
(en)
|
2021-02-24 |
2024-07-11 |
Alladapt Immunotherapeutics, Inc. |
Compositions and methods for identification of cross-reactive allergenic proteins and treatment of allergies
|
|
WO2022187440A1
(en)
|
2021-03-03 |
2022-09-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
La protien as a novel regulator of osteoclastogenesis
|
|
US20240310266A1
(en)
|
2021-03-18 |
2024-09-19 |
Novartis Ag |
Biomarkers for cancer and methods of use thereof
|
|
WO2022204581A2
(en)
|
2021-03-26 |
2022-09-29 |
Scholar Rock, Inc. |
Tgf-beta inhibitors and use thereof
|
|
TW202304979A
(zh)
|
2021-04-07 |
2023-02-01 |
瑞士商諾華公司 |
抗ＴＧＦβ抗體及其他治療劑用於治療增殖性疾病之用途
|
|
EP4320147A4
(en)
|
2021-04-08 |
2025-06-18 |
Marengo Therapeutics, Inc. |
TCR-BINDING MULTIFUNCTIONAL MOLECULES AND USES THEREOF
|
|
US20220362374A1
(en)
*
|
2021-04-29 |
2022-11-17 |
The Government Of The United States, As Represented By The Secretary Of The Army |
Antibodies Against Fentanyl and Fentanyl Analogs
|
|
JP2024519858A
(ja)
|
2021-05-18 |
2024-05-21 |
アボット・ラボラトリーズ |
小児対象における脳損傷を査定する方法
|
|
EP4348260A2
(en)
|
2021-06-03 |
2024-04-10 |
Scholar Rock, Inc. |
Tgf-beta inhibitors and therapeutic use thereof
|
|
BR112023022097A2
(pt)
|
2021-06-07 |
2023-12-19 |
Agonox Inc |
Cxcr5, pd-1 e icos expressando células t cd4 reativas de tumor e seu uso
|
|
US20240280561A1
(en)
|
2021-06-08 |
2024-08-22 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating and/or identifying an agent for treating intestinal cancers
|
|
US20240118279A1
(en)
|
2021-06-14 |
2024-04-11 |
Abbott Laboratories |
Methods of diagnosing or aiding in diagnosis of brain injury caused by acoustic energy, electromagnetic energy, an over pressurization wave, and/or blast wind
|
|
MX2023014840A
(es)
|
2021-06-23 |
2024-02-12 |
Scholar Rock Inc |
Un inhibidor de la vía de la miostatina en combinación con un activador de la vía de la glp-1 para su uso en el tratamiento de trastornos metabólicos.
|
|
AU2022310862A1
(en)
|
2021-07-14 |
2024-02-01 |
Regeneron Pharmaceuticals, Inc. |
Engineered t cell receptors fused to binding domains from antibodies
|
|
AU2022328390A1
(en)
|
2021-08-10 |
2024-03-21 |
Adimab, Llc |
Anti-gdf15 antibodies, compositions and uses thereof
|
|
EP4392780A1
(en)
|
2021-08-26 |
2024-07-03 |
Glycanostics s.r.o. |
Glycoprotein biomarkers for diagnosing cancer
|
|
CN118715440A
(zh)
|
2021-08-31 |
2024-09-27 |
雅培实验室 |
诊断脑损伤的方法和系统
|
|
AU2022339759A1
(en)
|
2021-08-31 |
2024-03-07 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
|
IL310815A
(en)
|
2021-09-14 |
2024-04-01 |
Glycanostics S R O |
Glycoprotein biomarkers for breast cancer diagnosis
|
|
US20250223376A1
(en)
|
2021-09-20 |
2025-07-10 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of her2 positive cancer
|
|
EP4405478A1
(en)
|
2021-09-20 |
2024-07-31 |
Alnylam Pharmaceuticals, Inc. |
Inhibin subunit beta e (inhbe) modulator compositions and methods of use thereof
|
|
EP4409294A1
(en)
|
2021-09-30 |
2024-08-07 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
|
CN118451101A
(zh)
|
2021-10-18 |
2024-08-06 |
百欧麦斯公司 |
抗激活素a抗体、组合物及其用途
|
|
WO2023092004A1
(en)
|
2021-11-17 |
2023-05-25 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of tau-related disorders
|
|
WO2023097254A1
(en)
|
2021-11-24 |
2023-06-01 |
Visterra, Inc. |
Engineered antibody molecules to cd138 and uses thereof
|
|
WO2023097119A2
(en)
|
2021-11-29 |
2023-06-01 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions to modulate riok2
|
|
MX2024006746A
(es)
|
2021-12-01 |
2024-08-09 |
Visterra Inc |
Métodos de uso de agentes de interleucina-2.
|
|
AU2022413677A1
(en)
|
2021-12-17 |
2024-06-27 |
Abbott Laboratories |
Systems and methods for determining uch-l1, gfap, and other biomarkers in blood samples
|
|
EP4452316A1
(en)
|
2021-12-22 |
2024-10-30 |
BYOMass Inc. |
Targeting gdf15-gfral pathway
|
|
EP4452305A1
(en)
|
2021-12-23 |
2024-10-30 |
Bavarian Nordic A/S |
Recombinant mva viruses for intraperitoneal administration for treating cancer
|
|
US20250109190A1
(en)
|
2022-01-31 |
2025-04-03 |
Byomass Inc. |
Myeloproliferative conditions
|
|
WO2023150652A1
(en)
|
2022-02-04 |
2023-08-10 |
Abbott Laboratories |
Lateral flow methods, assays, and devices for detecting the presence or measuring the amount of ubiquitin carboxy-terminal hydrolase l1 and/or glial fibrillary acidic protein in a sample
|
|
TW202342548A
(zh)
|
2022-02-07 |
2023-11-01 |
美商威特拉公司 |
抗獨特型(anti-idiotype)抗體分子及其用途
|
|
JP2025514142A
(ja)
|
2022-04-25 |
2025-05-02 |
ビステラ， インコーポレイテッド |
Ａｐｒｉｌに対する抗体分子およびその使用
|
|
WO2023220695A2
(en)
|
2022-05-13 |
2023-11-16 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of her2 positive cancer
|
|
EP4296279A1
(en)
|
2022-06-23 |
2023-12-27 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Anti-transthyretin (ttr) binding proteins and uses thereof
|
|
AU2023298134A1
(en)
|
2022-06-29 |
2024-11-28 |
Abbott Laboratories |
Magnetic point-of-care systems and assays for determining gfap in biological samples
|
|
TW202435912A
(zh)
|
2022-08-03 |
2024-09-16 |
美商航海家醫療公司 |
用於穿過血腦屏障之組合物及方法
|
|
KR20250068723A
(ko)
|
2022-09-15 |
2025-05-16 |
아보트 러보러터리즈 |
경증 및 초경증 외상성 뇌 손상을 구분하기 위한 바이오마커 및 방법
|
|
EP4590400A1
(en)
|
2022-09-21 |
2025-07-30 |
Elthera AG |
Novel binding molecules binding to l1cam
|
|
WO2024138076A1
(en)
|
2022-12-22 |
2024-06-27 |
Scholar Rock, Inc. |
Selective and potent inhibitory antibodies of myostatin activation
|
|
WO2024168061A2
(en)
|
2023-02-07 |
2024-08-15 |
Ayan Therapeutics Inc. |
Antibody molecules binding to sars-cov-2
|
|
WO2024196814A1
(en)
|
2023-03-17 |
2024-09-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods for treatment of age-related macular degeneration
|
|
WO2024211475A1
(en)
|
2023-04-04 |
2024-10-10 |
Abbott Laboratories |
Use of biomarkers to determine whether a subject has sustained, may have sustained or is suspected of sustaining a subacute acquired brain injury (abi)
|
|
WO2024226969A1
(en)
|
2023-04-28 |
2024-10-31 |
Abbott Point Of Care Inc. |
Improved assays, cartridges, and kits for detection of biomarkers, including brain injury biomarkers
|
|
WO2024240634A1
(en)
|
2023-05-19 |
2024-11-28 |
Les Laboratoires Servier |
Anti-met antibodies, antibody-drug conjugates, compositions and uses thereof
|
|
WO2025068389A2
(en)
|
2023-09-27 |
2025-04-03 |
Elthera Ag |
L1cam binding molecules for treating hematological malignancy diseases
|
|
WO2025122634A1
(en)
|
2023-12-05 |
2025-06-12 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of tau-related disorders
|
|
WO2025147500A1
(en)
|
2024-01-03 |
2025-07-10 |
Kiniksa Pharmaceuticals, Gmbh |
Method of reducing aggregation in the virus-inactivated preparation of anti-cd40 antibodies
|